Kengyong888 personal page - To The Moon

Kengyong888

Kengyong888

No personal profile

434Follow

7Followers

0Topic

0Badge

2022-12-01

$NASDAQ(.IXIC)$

2022-06-20

👍

STI Down 0.05% on Monday Despite Modest Wall Street Gains Last Week

2022-01-24

Huat !

4 Stocks That Can Turn $100,000 Into $1 Million by 2030

2021-12-31

Visa !

These dividend-paying companies can help to fade big tech and play a broader economic recovery

2021-09-24

Yup… can travel

Lifting international travel restrictions will boost U.S. economy -Commerce chief

2021-08-24

$Gritstone Oncology Inc.(GRTS)$Time to re-test $9 again ! Most Bio stocks are on the rise yesterday and with Pfizer acquisition of TRIL, this May be in play !

2021-08-18

$Gritstone Oncology Inc.(GRTS)$KOL presentation and sharing of prelim trial results tomorrow at 11 EST. Time to go above $9 !!!

2021-08-18

Huat !

Sorry, the original content has been removed

2021-08-14

$Gritstone Oncology Inc.(GRTS)$Trending up from Low of $6.4…. Presentation coming up on Tuesday

2021-08-11

Someone postulated Poison pill theory in another forum !

BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.

2021-08-11

Short covering today !!

BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.

2021-08-11

Let’s see whether they issue PR today to shedmore light !!

BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.

2021-08-06

$Gritstone Oncology Inc.(GRTS)$Heavy manipulated from $10+ down to $6.4 !

2021-08-06

$Gritstone Oncology Inc.(GRTS)$BO may be imminent! !

2021-08-01

$Gritstone Oncology Inc.(GRTS)$If the trial of 2nd gen covid vaccine is positive, this will be explosive !

2021-08-01

$Gritstone Oncology Inc.(GRTS)$Expect to see few PR on several of their trial results in Aug or Sep. This may push share price to doubledigits !

2021-07-28

Coffee sells

Sorry, the original content has been removed

2021-07-22

$Biocryst Pharmaceuticals(BCRX)$2Q results to be released on 5th Aug EST morning… today seeking alpha got a positive write up… May dip early morning but close green imo

2021-07-11

$BriaCell Therapeutics Corp.(BCTX)$One of the largest % gainers last Friday…. Went up high of 6.44 buy closed at 5.63. Next week presentation at virtual conf… will retest above $6 again !

2021-07-11

$Oncternal Therapeutics, Inc.(ONCT)$This probably one of the most undervalued biocancer stocks… waiting for BO and will load more if it dips to 4.3…

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3586309751267683","uuid":"3586309751267683","gmtCreate":1623221122945,"gmtModify":1629340907361,"name":"Kengyong888","pinyin":"kengyong888","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":7,"headSize":434,"tweetSize":57,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.03.06","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.06.23","exceedPercentage":"93.31%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"44212b71d0be4ec88898348dbe882e03-3","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"President Tiger","description":"The transaction amount of the securities account reaches $1,000,000","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.24","exceedPercentage":"93.50%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":9962791759,"gmtCreate":1669845481371,"gmtModify":1676538253626,"author":{"id":"3586309751267683","authorId":"3586309751267683","name":"Kengyong888","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586309751267683","authorIdStr":"3586309751267683"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/.IXIC\">$NASDAQ(.IXIC)$&nbsp;</a>","listText":"<a href=\"https://ttm.financial/S/.IXIC\">$NASDAQ(.IXIC)$&nbsp;</a>","text":"$NASDAQ(.IXIC)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9962791759","isVote":1,"tweetType":1,"viewCount":557,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9049066094,"gmtCreate":1655723701418,"gmtModify":1676535692882,"author":{"id":"3586309751267683","authorId":"3586309751267683","name":"Kengyong888","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586309751267683","authorIdStr":"3586309751267683"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9049066094","repostId":"1138048832","repostType":4,"repost":{"id":"1138048832","pubTimestamp":1655719091,"share":"https://ttm.financial/m/news/1138048832?lang=&edition=fundamental","pubTime":"2022-06-20 17:58","market":"sg","language":"en","title":"STI Down 0.05% on Monday Despite Modest Wall Street Gains Last Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1138048832","media":"The Business Times","summary":"SINGAPORE stocks fell on Monday (Jun 20) despite Wall Street’s modest gains last Friday.The benchmar","content":"<html><head></head><body><p>SINGAPORE stocks fell on Monday (Jun 20) despite Wall Street’s modest gains last Friday.</p><p>The benchmark Straits Times Index (STI) moved down 0.05 per cent or 1.69 points to 3,096.4. Across the broader market, losers outnumbered gainers 273 to 233 after 1.02 billion securities worth S$813.5 million changed hands.</p><p>Major indexes in Japan, South Korea and Australia fared worse, falling between 0.6 per cent and 2 per cent. However, Hong Kong’s Hang Seng Index bucked the Asian trend, closing up 0.4 per cent.</p><p>Despite Nasdaq’s 1.4 per cent bounce last Friday, Mizuho Bank’s head of economics and strategy Vishnu Varathan said it “may not be wise to imagine that markets are out of the wood” as US equities are down about 4.8 per cent to 5.8 per cent.</p><p>IG market strategist Yeap Jun Rong added that some caution remains as there is, for now, “no clear catalyst” that is likely to drive a sustained recovery in risk sentiments.</p><p>Among STI constituents, diversified business group Jardine Matheson Holdings : J36 was the biggest gainer, closing 1.9 per cent or US$0.94 higher at US$51. Trailing behind is property developer UOL : U14, which closed up 1.8 per cent or S$0.13 at S$7.24.</p><p>Finishing at the bottom of the STI performance table were Hongkong Land : H78, which shed 3.6 per cent or US$0.18 to close at US$4.82, and Yangzijiang Shipbuilding : BS6, which lost 2.5 per cent or S$0.025 to close at S$0.965.</p><p>The trio of local banks closed mixed; DBS : D05 and UOB : U11 rose 0.07 per cent and 0.04 per cent respectively to end at S$29.91 and S$26.84, while OCBC : O39 slipped 0.2 per cent to S$11.40.</p><p>In the broader market, the most actively traded counter by volume was Sembcorp Marine : S51 -3.67%, which closed down 3.7 per cent or S$0.004 at S$0.105 after some 67.9 million of its shares worth S$7.2 million exchanged hands.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>STI Down 0.05% on Monday Despite Modest Wall Street Gains Last Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSTI Down 0.05% on Monday Despite Modest Wall Street Gains Last Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-06-20 17:58 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.businesstimes.com.sg/companies-markets/sti-down-005-on-monday-despite-modest-wall-street-gains-last-week><strong>The Business Times</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SINGAPORE stocks fell on Monday (Jun 20) despite Wall Street’s modest gains last Friday.The benchmark Straits Times Index (STI) moved down 0.05 per cent or 1.69 points to 3,096.4. Across the broader ...</p>\n\n<a href=\"https://www.businesstimes.com.sg/companies-markets/sti-down-005-on-monday-despite-modest-wall-street-gains-last-week\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STI.SI":"富时新加坡海峡指数"},"source_url":"https://www.businesstimes.com.sg/companies-markets/sti-down-005-on-monday-despite-modest-wall-street-gains-last-week","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1138048832","content_text":"SINGAPORE stocks fell on Monday (Jun 20) despite Wall Street’s modest gains last Friday.The benchmark Straits Times Index (STI) moved down 0.05 per cent or 1.69 points to 3,096.4. Across the broader market, losers outnumbered gainers 273 to 233 after 1.02 billion securities worth S$813.5 million changed hands.Major indexes in Japan, South Korea and Australia fared worse, falling between 0.6 per cent and 2 per cent. However, Hong Kong’s Hang Seng Index bucked the Asian trend, closing up 0.4 per cent.Despite Nasdaq’s 1.4 per cent bounce last Friday, Mizuho Bank’s head of economics and strategy Vishnu Varathan said it “may not be wise to imagine that markets are out of the wood” as US equities are down about 4.8 per cent to 5.8 per cent.IG market strategist Yeap Jun Rong added that some caution remains as there is, for now, “no clear catalyst” that is likely to drive a sustained recovery in risk sentiments.Among STI constituents, diversified business group Jardine Matheson Holdings : J36 was the biggest gainer, closing 1.9 per cent or US$0.94 higher at US$51. Trailing behind is property developer UOL : U14, which closed up 1.8 per cent or S$0.13 at S$7.24.Finishing at the bottom of the STI performance table were Hongkong Land : H78, which shed 3.6 per cent or US$0.18 to close at US$4.82, and Yangzijiang Shipbuilding : BS6, which lost 2.5 per cent or S$0.025 to close at S$0.965.The trio of local banks closed mixed; DBS : D05 and UOB : U11 rose 0.07 per cent and 0.04 per cent respectively to end at S$29.91 and S$26.84, while OCBC : O39 slipped 0.2 per cent to S$11.40.In the broader market, the most actively traded counter by volume was Sembcorp Marine : S51 -3.67%, which closed down 3.7 per cent or S$0.004 at S$0.105 after some 67.9 million of its shares worth S$7.2 million exchanged hands.","news_type":1},"isVote":1,"tweetType":1,"viewCount":259,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9007777464,"gmtCreate":1643028224710,"gmtModify":1676533765995,"author":{"id":"3586309751267683","authorId":"3586309751267683","name":"Kengyong888","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586309751267683","authorIdStr":"3586309751267683"},"themes":[],"htmlText":"Huat !","listText":"Huat !","text":"Huat !","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9007777464","repostId":"2205802723","repostType":4,"repost":{"id":"2205802723","pubTimestamp":1643037267,"share":"https://ttm.financial/m/news/2205802723?lang=&edition=fundamental","pubTime":"2022-01-24 23:14","market":"us","language":"en","title":"4 Stocks That Can Turn $100,000 Into $1 Million by 2030","url":"https://stock-news.laohu8.com/highlight/detail?id=2205802723","media":"Motley Fool","summary":"With time as an investors' ally, these game-changing stocks can make people rich.","content":"<html><head></head><body><p>Since the stock market bottomed out in March 2020, investors have enjoyed historic gains. It took less than 17 months for the broad-based <b>S&amp;P 500</b> to double from its bear market low. Furthermore, the widely followed index came close to tripling its long-term average annual return in 2021.</p><p>Despite this incredible outperformance, amazing deals remain. Patient investors who buy into innovative companies with clear-cut competitive advantages have a real chance to see their initial investment compound many times over.</p><p>If you have cash ready to invest and are willing to let time be your ally, the following four stocks all have the tools to turn $100,000 into $1 million by 2030.</p><p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F660582%2Fstack-of-one-hundred-dollar-bills-cash-money-invest-retire-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"491\" referrerpolicy=\"no-referrer\"/><span>Image source: Getty Images.</span></p><h2>Teladoc Health</h2><p>There&#39;s no sugarcoating it: telehealth giant <b>Teladoc Health</b> (NYSE:TDOC) was <a href=\"https://laohu8.com/S/AONE.U\">one</a> of 2021&#39;s biggest disappointments. After skyrocketing during the initial stages of the coronavirus pandemic, concerns about larger-than-expected losses tied to its Livongo Health acquisition, as well as worries about slowing growth in an eventual post-pandemic world, pushed shares more than 70% below their all-time high.</p><p>However, investors with time on their side can buy Teladoc Health now and take pride in owning a leading innovator in personalized care.</p><p>The easiest way to tell that that telemedicine is here to stay is to look at Teladoc&#39;s sales growth prior to the pandemic. In the seven years leading up to the coronavirus outbreak, the company averaged annual sales growth of 74%. That&#39;s not a year or two of simply being in the right place at the right time. Sales growth this consistent signals a sustained shift in how treatment is being administered in the U.S.</p><p>The great thing about telemedicine is that it provides benefits up and down the treatment chain. It&#39;s almost always more convenient for patients, and it can allow physicians easier access to chronically ill patients. This ease of access should result in improved patient outcomes and lower costs for health insurance companies. The latter is particularly important, as it could increase the likelihood that insurers will push for increased telehealth adoption in the years that lie ahead.</p><p>What&#39;s more, the higher costs associated with Teladoc&#39;s buyout of leading applied health signals company Livongo Health won&#39;t carry over into its 2022 financial results. This means investors can focus on what&#39;s important -- i.e., Livongo&#39;s efforts to enroll more chronic-care members in its service.</p><p>Teladoc has the solutions and innovation to be one of the fastest-growing healthcare stocks this decade.</p><p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F660582%2Fbusiness-meeting-tablets-laptops-graphs-charts-advertising-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"/><span>Image source: Getty Images.</span></p><h2>PubMatic</h2><p>A small-cap growth stock with large-cap aspirations that could realistically 10x investors&#39; money by the turn of the decade is <b>PubMatic</b> (NASDAQ:PUBM).</p><p>PubMatic operates as a cloud-based, sell-side programmatic ad platform. In simple terms, this means PubMatic&#39;s solutions handle the optimization of ad placement for its clients, the publishers selling their display space. While publishers do offer some level of input, such as the minimum price they&#39;d be willing to accept for their display space, it&#39;s PubMatic&#39;s programmatic ad platform that handles everything else.</p><p>What makes PubMatic such a no-brainer buy over the long term is the undeniable shift of advertising dollars to digital platforms. According to the company, global digital ad spend is expected to grow by an annual rate of 10% through 2024, with respective compound annual growth rates of 11%, 17%, and 11% for mobile, video, and connected TV (CTV)/over-the-top programmatic ads through mid-decade.</p><p>However, PubMatic&#39;s growth rate has consistently more than doubled industrywide estimates. In the third quarter alone, mobile and omnichannel video, which includes CTV, grew by 64% from the year-ago period. This digital omnichannel ad growth is precisely why PubMatic has reported four consecutive quarters of organic growth of at least 50%.</p><p>With the shift to digital ad spending picking up steam, PubMatic looks to be the best name to own in the programmatic ad space.</p><p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F660582%2Fa-key-unlocking-blockchain-digital-id-security-hacker-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"/><span>Image source: Getty Images.</span></p><h2>Ping Identity Holdings</h2><p>Another fast-paced small-cap stock with the ability to turn $100,000 into $1 million by 2030 is cybersecurity company <b>Ping Identity</b> (NYSE:PING).</p><p>Cybersecurity is what I believe will be the safest sustainable double-digit growth trend throughout the decade. With more businesses than ever moving their data into the cloud during the pandemic, demand for third-party solutions to safeguard this information has skyrocketed. Since hackers and robots don&#39;t take a day off, the solutions provided by Ping Identity and its peers have effectively become basic-need services.</p><p>As its name implies, Ping&#39;s cloud-based and artificial intelligence-driven platform is primarily focused on identity verification. It&#39;s particularly effective when layered with on-premises solutions to assist with continuous verifications, risk assessment, and authorization (all areas where on-premises solutions may come up short).</p><p>What makes Ping Identity such an incredible deal is the company&#39;s temporary underperformance during the initial stages of the pandemic. The uncertainty of the pandemic led some of its customers to choose shorter time frames for their term-based licenses in 2020. While that was bad news for Ping&#39;s short-term revenue growth, it didn&#39;t slow the company&#39;s annual recurring revenue (ARR) growth, which has averaged in the mid-to-high teens. Since nearly all of Ping&#39;s revenue is derived from subscriptions, ARR is a much better indicator of Ping&#39;s overall health.</p><p>Ping Identity is profitable and steadily shifting clients to its high-margin software-as-a-service cybersecurity solutions over time. That&#39;s a recipe for success.</p><p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F660582%2Fwoman-testing-server-data-center-network-wireless-iot-business-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"/><span>Image source: Getty Images.</span></p><h2>Fastly</h2><p>A fourth fast-growing company that can turn $100,000 into $1 million for investors by 2030 is edge cloud computing stock <b>Fastly</b> (NYSE:FSLY). The company is perhaps best known for being a content delivery network (i.e., it expedites the delivery of content to end users while maintaining/bolstering network security).</p><p>Similar to Teladoc, Fastly was creamed after the mid-February 2021 peak in growth stocks. Wall Street has been concerned with Fastly&#39;s wider-than-expected losses tied to higher head count and increased marketing expenses. Additionally, Fastly faced a backlash in June after a brief outage on its network disrupted service for a number of popular clients.</p><p>Although an outage isn&#39;t good news, this temporary disruption is now in the rearview mirror. More importantly, the outage hasn&#39;t cost Fastly its core clients. Third-quarter operating data showed sequential increases in enterprise customer count, average enterprise customer spend, and net retention rates.</p><p>Fastly&#39;s allure also has to do with its potential role in the metaverse. The metaverse is the next iteration of the internet, designed to let users interact with 3D virtual environments. One of the biggest challenges of the metaverse will be reducing latency and eliminating any lag following decisions or movements made in virtual worlds. Fastly&#39;s network should be leaned on heavily as the metaverse takes shape in the years to come.</p><p>With an adjusted gross margin that&#39;s consistently come in between 57% and 62%, Fastly is a good bet to net patient investors a whopper of a return over the long run.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>4 Stocks That Can Turn $100,000 Into $1 Million by 2030</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n4 Stocks That Can Turn $100,000 Into $1 Million by 2030\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-24 23:14 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/23/4-stocks-can-turn-100000-into-1-million-by-2030/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Since the stock market bottomed out in March 2020, investors have enjoyed historic gains. It took less than 17 months for the broad-based S&P 500 to double from its bear market low. Furthermore, the ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/23/4-stocks-can-turn-100000-into-1-million-by-2030/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"FSLY":"Fastly, Inc.","BK4009":"广告","BK4548":"巴美列捷福持仓","PING":"Ping Identity Holding","BK4110":"抵押房地产投资信托","TDOC":"Teladoc Health Inc.","BK4167":"医疗保健技术","BK4097":"系统软件","BK4534":"瑞士信贷持仓","BK4567":"ESG概念","BK4116":"互联网服务与基础架构","BK4504":"桥水持仓","ARR":"ARMOUR住宅房地产公司","CTV":"Innovid","BK4554":"元宇宙及AR概念","PUBM":"PubMatic, Inc."},"source_url":"https://www.fool.com/investing/2022/01/23/4-stocks-can-turn-100000-into-1-million-by-2030/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2205802723","content_text":"Since the stock market bottomed out in March 2020, investors have enjoyed historic gains. It took less than 17 months for the broad-based S&P 500 to double from its bear market low. Furthermore, the widely followed index came close to tripling its long-term average annual return in 2021.Despite this incredible outperformance, amazing deals remain. Patient investors who buy into innovative companies with clear-cut competitive advantages have a real chance to see their initial investment compound many times over.If you have cash ready to invest and are willing to let time be your ally, the following four stocks all have the tools to turn $100,000 into $1 million by 2030.Image source: Getty Images.Teladoc HealthThere's no sugarcoating it: telehealth giant Teladoc Health (NYSE:TDOC) was one of 2021's biggest disappointments. After skyrocketing during the initial stages of the coronavirus pandemic, concerns about larger-than-expected losses tied to its Livongo Health acquisition, as well as worries about slowing growth in an eventual post-pandemic world, pushed shares more than 70% below their all-time high.However, investors with time on their side can buy Teladoc Health now and take pride in owning a leading innovator in personalized care.The easiest way to tell that that telemedicine is here to stay is to look at Teladoc's sales growth prior to the pandemic. In the seven years leading up to the coronavirus outbreak, the company averaged annual sales growth of 74%. That's not a year or two of simply being in the right place at the right time. Sales growth this consistent signals a sustained shift in how treatment is being administered in the U.S.The great thing about telemedicine is that it provides benefits up and down the treatment chain. It's almost always more convenient for patients, and it can allow physicians easier access to chronically ill patients. This ease of access should result in improved patient outcomes and lower costs for health insurance companies. The latter is particularly important, as it could increase the likelihood that insurers will push for increased telehealth adoption in the years that lie ahead.What's more, the higher costs associated with Teladoc's buyout of leading applied health signals company Livongo Health won't carry over into its 2022 financial results. This means investors can focus on what's important -- i.e., Livongo's efforts to enroll more chronic-care members in its service.Teladoc has the solutions and innovation to be one of the fastest-growing healthcare stocks this decade.Image source: Getty Images.PubMaticA small-cap growth stock with large-cap aspirations that could realistically 10x investors' money by the turn of the decade is PubMatic (NASDAQ:PUBM).PubMatic operates as a cloud-based, sell-side programmatic ad platform. In simple terms, this means PubMatic's solutions handle the optimization of ad placement for its clients, the publishers selling their display space. While publishers do offer some level of input, such as the minimum price they'd be willing to accept for their display space, it's PubMatic's programmatic ad platform that handles everything else.What makes PubMatic such a no-brainer buy over the long term is the undeniable shift of advertising dollars to digital platforms. According to the company, global digital ad spend is expected to grow by an annual rate of 10% through 2024, with respective compound annual growth rates of 11%, 17%, and 11% for mobile, video, and connected TV (CTV)/over-the-top programmatic ads through mid-decade.However, PubMatic's growth rate has consistently more than doubled industrywide estimates. In the third quarter alone, mobile and omnichannel video, which includes CTV, grew by 64% from the year-ago period. This digital omnichannel ad growth is precisely why PubMatic has reported four consecutive quarters of organic growth of at least 50%.With the shift to digital ad spending picking up steam, PubMatic looks to be the best name to own in the programmatic ad space.Image source: Getty Images.Ping Identity HoldingsAnother fast-paced small-cap stock with the ability to turn $100,000 into $1 million by 2030 is cybersecurity company Ping Identity (NYSE:PING).Cybersecurity is what I believe will be the safest sustainable double-digit growth trend throughout the decade. With more businesses than ever moving their data into the cloud during the pandemic, demand for third-party solutions to safeguard this information has skyrocketed. Since hackers and robots don't take a day off, the solutions provided by Ping Identity and its peers have effectively become basic-need services.As its name implies, Ping's cloud-based and artificial intelligence-driven platform is primarily focused on identity verification. It's particularly effective when layered with on-premises solutions to assist with continuous verifications, risk assessment, and authorization (all areas where on-premises solutions may come up short).What makes Ping Identity such an incredible deal is the company's temporary underperformance during the initial stages of the pandemic. The uncertainty of the pandemic led some of its customers to choose shorter time frames for their term-based licenses in 2020. While that was bad news for Ping's short-term revenue growth, it didn't slow the company's annual recurring revenue (ARR) growth, which has averaged in the mid-to-high teens. Since nearly all of Ping's revenue is derived from subscriptions, ARR is a much better indicator of Ping's overall health.Ping Identity is profitable and steadily shifting clients to its high-margin software-as-a-service cybersecurity solutions over time. That's a recipe for success.Image source: Getty Images.FastlyA fourth fast-growing company that can turn $100,000 into $1 million for investors by 2030 is edge cloud computing stock Fastly (NYSE:FSLY). The company is perhaps best known for being a content delivery network (i.e., it expedites the delivery of content to end users while maintaining/bolstering network security).Similar to Teladoc, Fastly was creamed after the mid-February 2021 peak in growth stocks. Wall Street has been concerned with Fastly's wider-than-expected losses tied to higher head count and increased marketing expenses. Additionally, Fastly faced a backlash in June after a brief outage on its network disrupted service for a number of popular clients.Although an outage isn't good news, this temporary disruption is now in the rearview mirror. More importantly, the outage hasn't cost Fastly its core clients. Third-quarter operating data showed sequential increases in enterprise customer count, average enterprise customer spend, and net retention rates.Fastly's allure also has to do with its potential role in the metaverse. The metaverse is the next iteration of the internet, designed to let users interact with 3D virtual environments. One of the biggest challenges of the metaverse will be reducing latency and eliminating any lag following decisions or movements made in virtual worlds. Fastly's network should be leaned on heavily as the metaverse takes shape in the years to come.With an adjusted gross margin that's consistently come in between 57% and 62%, Fastly is a good bet to net patient investors a whopper of a return over the long run.","news_type":1},"isVote":1,"tweetType":1,"viewCount":715,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9003638760,"gmtCreate":1640956669071,"gmtModify":1676533558409,"author":{"id":"3586309751267683","authorId":"3586309751267683","name":"Kengyong888","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586309751267683","authorIdStr":"3586309751267683"},"themes":[],"htmlText":"Visa !","listText":"Visa !","text":"Visa !","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9003638760","repostId":"2195641730","repostType":4,"repost":{"id":"2195641730","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1640953756,"share":"https://ttm.financial/m/news/2195641730?lang=&edition=fundamental","pubTime":"2021-12-31 20:29","market":"us","language":"en","title":"These dividend-paying companies can help to fade big tech and play a broader economic recovery","url":"https://stock-news.laohu8.com/highlight/detail?id=2195641730","media":"Dow Jones","summary":"If 2020 was the year for the stay-at-home stocks, well, 2021 wasn't. Bloomberg columnist John Auther","content":"<html><head></head><body><p>If 2020 was the year for the stay-at-home stocks, well, 2021 wasn&#39;t. Bloomberg columnist John Authers points out that an investor who shorted the S&amp;P 500 home entertainment stocks and invested in regional malls instead would have returned a hefty 120% gain this year.</p><p>So is the recovery story totally done? Maybe not. Need to Know recently examined what an artificial intelligence-driven portfolio manager was doing -- shedding big tech names such as Microsoft, Alphabet and Amazon.com for a more well-rounded portfolio.</p><p>Kevin Muir, author of the Macro Tourist blog and a former institutional equity derivatives trader, is expecting what he calls a violent rotation out of large-cap growth into more value-type names in the first quarter. U.S. economic growth is shifting to one driven by the lower end of the wealth spectrum, boosted by fiscal instead of monetary stimulus, which will lead to what he calls a regular, old-fashioned economic expansion. &#34;This means stocks like industrials and other boring companies that facilitate traditional economic growth are what you want to own,&#34; he writes.</p><p>But how to do that? There&#39;s an exchange-traded fund, the ProShares S&amp;P 500 Dividend Aristrocrats, based on an index that limits membership to S&amp;P 500 companies that have raised their dividend for 25 consecutive years. MarketWatch data show the fund&#39;s top sector exposures are industrials, with a 23% weighting, and consumer goods, with 20%, and only 3% exposure to technology.</p><p>The opposite, says Muir, of a zero-coupon-like growth stock would be a high-paying stable dividend company. &#34;If you are looking for a way to fade the Top 8 basket dominance, then what better way than owning a bunch of companies that pay regular dividends, aren&#39;t bid to the moon with speculative exuberance, and will participate in the upcoming economic upswing,&#34; says Muir.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These dividend-paying companies can help to fade big tech and play a broader economic recovery</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese dividend-paying companies can help to fade big tech and play a broader economic recovery\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-12-31 20:29</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>If 2020 was the year for the stay-at-home stocks, well, 2021 wasn&#39;t. Bloomberg columnist John Authers points out that an investor who shorted the S&amp;P 500 home entertainment stocks and invested in regional malls instead would have returned a hefty 120% gain this year.</p><p>So is the recovery story totally done? Maybe not. Need to Know recently examined what an artificial intelligence-driven portfolio manager was doing -- shedding big tech names such as Microsoft, Alphabet and Amazon.com for a more well-rounded portfolio.</p><p>Kevin Muir, author of the Macro Tourist blog and a former institutional equity derivatives trader, is expecting what he calls a violent rotation out of large-cap growth into more value-type names in the first quarter. U.S. economic growth is shifting to one driven by the lower end of the wealth spectrum, boosted by fiscal instead of monetary stimulus, which will lead to what he calls a regular, old-fashioned economic expansion. &#34;This means stocks like industrials and other boring companies that facilitate traditional economic growth are what you want to own,&#34; he writes.</p><p>But how to do that? There&#39;s an exchange-traded fund, the ProShares S&amp;P 500 Dividend Aristrocrats, based on an index that limits membership to S&amp;P 500 companies that have raised their dividend for 25 consecutive years. MarketWatch data show the fund&#39;s top sector exposures are industrials, with a 23% weighting, and consumer goods, with 20%, and only 3% exposure to technology.</p><p>The opposite, says Muir, of a zero-coupon-like growth stock would be a high-paying stable dividend company. &#34;If you are looking for a way to fade the Top 8 basket dominance, then what better way than owning a bunch of companies that pay regular dividends, aren&#39;t bid to the moon with speculative exuberance, and will participate in the upcoming economic upswing,&#34; says Muir.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4097":"系统软件","MA":"万事达","MRK":"默沙东","BK4504":"桥水持仓","GOOGL":"谷歌A","NOBL":"ProShares S&P 500 Aristocrats ETF","BK4548":"巴美列捷福持仓","BK4514":"搜索引擎","XOM":"埃克森美孚","BK4201":"综合性石油与天然气企业","BK4528":"SaaS概念","BK4516":"特朗普概念","BK4554":"元宇宙及AR概念","BK4122":"互联网与直销零售","MSFT":"微软","BK4532":"文艺复兴科技持仓","AMZN":"亚马逊","BK4567":"ESG概念","BK4534":"瑞士信贷持仓","BK4507":"流媒体概念","BK4007":"制药","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4566":"资本集团","V":"Visa","BK4525":"远程办公概念","BK4535":"淡马锡持仓","BK4524":"宅经济概念","BK4559":"巴菲特持仓","BK4538":"云计算","BK4527":"明星科技股","BK4077":"互动媒体与服务","BK4568":"美国抗疫概念","BK4106":"数据处理与外包服务","PFE":"辉瑞","BK4550":"红杉资本持仓","BK4503":"景林资产持仓","BK4551":"寇图资本持仓","BK4561":"索罗斯持仓"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2195641730","content_text":"If 2020 was the year for the stay-at-home stocks, well, 2021 wasn't. Bloomberg columnist John Authers points out that an investor who shorted the S&P 500 home entertainment stocks and invested in regional malls instead would have returned a hefty 120% gain this year.So is the recovery story totally done? Maybe not. Need to Know recently examined what an artificial intelligence-driven portfolio manager was doing -- shedding big tech names such as Microsoft, Alphabet and Amazon.com for a more well-rounded portfolio.Kevin Muir, author of the Macro Tourist blog and a former institutional equity derivatives trader, is expecting what he calls a violent rotation out of large-cap growth into more value-type names in the first quarter. U.S. economic growth is shifting to one driven by the lower end of the wealth spectrum, boosted by fiscal instead of monetary stimulus, which will lead to what he calls a regular, old-fashioned economic expansion. \"This means stocks like industrials and other boring companies that facilitate traditional economic growth are what you want to own,\" he writes.But how to do that? There's an exchange-traded fund, the ProShares S&P 500 Dividend Aristrocrats, based on an index that limits membership to S&P 500 companies that have raised their dividend for 25 consecutive years. MarketWatch data show the fund's top sector exposures are industrials, with a 23% weighting, and consumer goods, with 20%, and only 3% exposure to technology.The opposite, says Muir, of a zero-coupon-like growth stock would be a high-paying stable dividend company. \"If you are looking for a way to fade the Top 8 basket dominance, then what better way than owning a bunch of companies that pay regular dividends, aren't bid to the moon with speculative exuberance, and will participate in the upcoming economic upswing,\" says Muir.","news_type":1},"isVote":1,"tweetType":1,"viewCount":471,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":861037819,"gmtCreate":1632441661431,"gmtModify":1676530782593,"author":{"id":"3586309751267683","authorId":"3586309751267683","name":"Kengyong888","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586309751267683","authorIdStr":"3586309751267683"},"themes":[],"htmlText":"Yup… can travel&nbsp;","listText":"Yup… can travel&nbsp;","text":"Yup… can travel","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":4,"repostSize":0,"link":"https://ttm.financial/post/861037819","repostId":"2169955066","repostType":4,"repost":{"id":"2169955066","pubTimestamp":1632441480,"share":"https://ttm.financial/m/news/2169955066?lang=&edition=fundamental","pubTime":"2021-09-24 07:58","market":"us","language":"en","title":"Lifting international travel restrictions will boost U.S. economy -Commerce chief","url":"https://stock-news.laohu8.com/highlight/detail?id=2169955066","media":"StreetInsider","summary":"WASHINGTON (Reuters) - U.S. Commerce Secretary Gina Raimondo said on Thursday that the decision by t","content":"<p>WASHINGTON (Reuters) - U.S. Commerce Secretary Gina Raimondo said on Thursday that the decision by the Biden administration to lift international travel restrictions in early November will be a boost to the U.S. economy, especially for tourist destinations like New York and for business travel.</p>\n<p>Raimondo said the decision announced Monday to allow fully vaccinated foreign nationals to fly to the United States \"is huge. I think it will really be a boost to our economy, it will certainly be a boost to travel, tourism, hospitality.\" To address COVID-19 concerns, the U.S. has barred most foreign nationals from coming to the United States who have recently been in 33 countries including China, South Africa, Brazil, India and much of Europe.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Lifting international travel restrictions will boost U.S. economy -Commerce chief</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLifting international travel restrictions will boost U.S. economy -Commerce chief\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-24 07:58 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18976210><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>WASHINGTON (Reuters) - U.S. Commerce Secretary Gina Raimondo said on Thursday that the decision by the Biden administration to lift international travel restrictions in early November will be a boost ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18976210\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LUV":"西南航空","AAL":"美国航空","UAL":"联合大陆航空"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18976210","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2169955066","content_text":"WASHINGTON (Reuters) - U.S. Commerce Secretary Gina Raimondo said on Thursday that the decision by the Biden administration to lift international travel restrictions in early November will be a boost to the U.S. economy, especially for tourist destinations like New York and for business travel.\nRaimondo said the decision announced Monday to allow fully vaccinated foreign nationals to fly to the United States \"is huge. I think it will really be a boost to our economy, it will certainly be a boost to travel, tourism, hospitality.\" To address COVID-19 concerns, the U.S. has barred most foreign nationals from coming to the United States who have recently been in 33 countries including China, South Africa, Brazil, India and much of Europe.","news_type":1},"isVote":1,"tweetType":1,"viewCount":755,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":834360631,"gmtCreate":1629772521723,"gmtModify":1676530126460,"author":{"id":"3586309751267683","authorId":"3586309751267683","name":"Kengyong888","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586309751267683","authorIdStr":"3586309751267683"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/GRTS\">$Gritstone Oncology Inc.(GRTS)$</a>Time to re-test $9 again ! Most&nbsp;Bio stocks are on the rise yesterday&nbsp;and with Pfizer acquisition of TRIL, this May be in play !","listText":"<a href=\"https://laohu8.com/S/GRTS\">$Gritstone Oncology Inc.(GRTS)$</a>Time to re-test $9 again ! Most&nbsp;Bio stocks are on the rise yesterday&nbsp;and with Pfizer acquisition of TRIL, this May be in play !","text":"$Gritstone Oncology Inc.(GRTS)$Time to re-test $9 again ! Most Bio stocks are on the rise yesterday and with Pfizer acquisition of TRIL, this May be in play !","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/834360631","isVote":1,"tweetType":1,"viewCount":643,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":833282936,"gmtCreate":1629245380325,"gmtModify":1676529975794,"author":{"id":"3586309751267683","authorId":"3586309751267683","name":"Kengyong888","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586309751267683","authorIdStr":"3586309751267683"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/GRTS\">$Gritstone Oncology Inc.(GRTS)$</a>KOL presentation and sharing of prelim trial results tomorrow at 11 EST. Time to go above $9 !!!","listText":"<a href=\"https://laohu8.com/S/GRTS\">$Gritstone Oncology Inc.(GRTS)$</a>KOL presentation and sharing of prelim trial results tomorrow at 11 EST. Time to go above $9 !!!","text":"$Gritstone Oncology Inc.(GRTS)$KOL presentation and sharing of prelim trial results tomorrow at 11 EST. Time to go above $9 !!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/833282936","isVote":1,"tweetType":1,"viewCount":642,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":833202134,"gmtCreate":1629243477028,"gmtModify":1676529974721,"author":{"id":"3586309751267683","authorId":"3586309751267683","name":"Kengyong888","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586309751267683","authorIdStr":"3586309751267683"},"themes":[],"htmlText":"Huat !","listText":"Huat !","text":"Huat !","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/833202134","repostId":"1154954467","repostType":4,"isVote":1,"tweetType":1,"viewCount":738,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":897241561,"gmtCreate":1628929542353,"gmtModify":1676529895944,"author":{"id":"3586309751267683","authorId":"3586309751267683","name":"Kengyong888","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586309751267683","authorIdStr":"3586309751267683"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/GRTS\">$Gritstone Oncology Inc.(GRTS)$</a>Trending up from Low of $6.4…. Presentation coming up on Tuesday","listText":"<a href=\"https://laohu8.com/S/GRTS\">$Gritstone Oncology Inc.(GRTS)$</a>Trending up from Low of $6.4…. Presentation coming up on Tuesday","text":"$Gritstone Oncology Inc.(GRTS)$Trending up from Low of $6.4…. Presentation coming up on Tuesday","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/897241561","isVote":1,"tweetType":1,"viewCount":857,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":892526680,"gmtCreate":1628674576240,"gmtModify":1676529817380,"author":{"id":"3586309751267683","authorId":"3586309751267683","name":"Kengyong888","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586309751267683","authorIdStr":"3586309751267683"},"themes":[],"htmlText":"Someone postulated&nbsp;Poison pill theory in another forum !","listText":"Someone postulated&nbsp;Poison pill theory in another forum !","text":"Someone postulated Poison pill theory in another forum !","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/892526680","repostId":"1172810796","repostType":4,"repost":{"id":"1172810796","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628671712,"share":"https://ttm.financial/m/news/1172810796?lang=&edition=fundamental","pubTime":"2021-08-11 16:48","market":"us","language":"en","title":"BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.","url":"https://stock-news.laohu8.com/highlight/detail?id=1172810796","media":"Tiger Newspress","summary":"BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.\nBioCryst ","content":"<p>BioCryst&nbsp;shares&nbsp;jumped&nbsp;10.49%&nbsp;in&nbsp;premarket&nbsp;trading,as&nbsp;withdrawing previous stock offering.</p>\n<p><img src=\"https://static.tigerbbs.com/c15bfde15a241770cbb0410850f6460f\" tg-width=\"900\" tg-height=\"624\" referrerpolicy=\"no-referrer\">BioCryst Pharmaceuticals, Inc. &nbsp;announced today that it has withdrawn its proposed public offering. With our strong balance sheet, and increasing revenues from ORLADEYO<b>®</b> (berotralstat), we believe that current market conditions are not conducive to an offering on terms that would be in the best interests of our current stockholders.&nbsp;&nbsp; We are well capitalized, with cash, cash equivalents, restricted cash and investments of $222.8 million as of June 30, 2021.&nbsp;&nbsp; Based on our expectations for revenue, operating expenses, and our option to access an additional $75 million from our existing credit facility, we believe our current cash runway takes us into 2023.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-11 16:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BioCryst&nbsp;shares&nbsp;jumped&nbsp;10.49%&nbsp;in&nbsp;premarket&nbsp;trading,as&nbsp;withdrawing previous stock offering.</p>\n<p><img src=\"https://static.tigerbbs.com/c15bfde15a241770cbb0410850f6460f\" tg-width=\"900\" tg-height=\"624\" referrerpolicy=\"no-referrer\">BioCryst Pharmaceuticals, Inc. &nbsp;announced today that it has withdrawn its proposed public offering. With our strong balance sheet, and increasing revenues from ORLADEYO<b>®</b> (berotralstat), we believe that current market conditions are not conducive to an offering on terms that would be in the best interests of our current stockholders.&nbsp;&nbsp; We are well capitalized, with cash, cash equivalents, restricted cash and investments of $222.8 million as of June 30, 2021.&nbsp;&nbsp; Based on our expectations for revenue, operating expenses, and our option to access an additional $75 million from our existing credit facility, we believe our current cash runway takes us into 2023.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BCRX":"BioCryst制药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1172810796","content_text":"BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.\nBioCryst Pharmaceuticals, Inc.  announced today that it has withdrawn its proposed public offering. With our strong balance sheet, and increasing revenues from ORLADEYO® (berotralstat), we believe that current market conditions are not conducive to an offering on terms that would be in the best interests of our current stockholders.   We are well capitalized, with cash, cash equivalents, restricted cash and investments of $222.8 million as of June 30, 2021.   Based on our expectations for revenue, operating expenses, and our option to access an additional $75 million from our existing credit facility, we believe our current cash runway takes us into 2023.","news_type":1},"isVote":1,"tweetType":1,"viewCount":569,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":892565988,"gmtCreate":1628673652244,"gmtModify":1676529817166,"author":{"id":"3586309751267683","authorId":"3586309751267683","name":"Kengyong888","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586309751267683","authorIdStr":"3586309751267683"},"themes":[],"htmlText":"Short covering today !!","listText":"Short covering today !!","text":"Short covering today !!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/892565988","repostId":"1172810796","repostType":4,"repost":{"id":"1172810796","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628671712,"share":"https://ttm.financial/m/news/1172810796?lang=&edition=fundamental","pubTime":"2021-08-11 16:48","market":"us","language":"en","title":"BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.","url":"https://stock-news.laohu8.com/highlight/detail?id=1172810796","media":"Tiger Newspress","summary":"BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.\nBioCryst ","content":"<p>BioCryst&nbsp;shares&nbsp;jumped&nbsp;10.49%&nbsp;in&nbsp;premarket&nbsp;trading,as&nbsp;withdrawing previous stock offering.</p>\n<p><img src=\"https://static.tigerbbs.com/c15bfde15a241770cbb0410850f6460f\" tg-width=\"900\" tg-height=\"624\" referrerpolicy=\"no-referrer\">BioCryst Pharmaceuticals, Inc. &nbsp;announced today that it has withdrawn its proposed public offering. With our strong balance sheet, and increasing revenues from ORLADEYO<b>®</b> (berotralstat), we believe that current market conditions are not conducive to an offering on terms that would be in the best interests of our current stockholders.&nbsp;&nbsp; We are well capitalized, with cash, cash equivalents, restricted cash and investments of $222.8 million as of June 30, 2021.&nbsp;&nbsp; Based on our expectations for revenue, operating expenses, and our option to access an additional $75 million from our existing credit facility, we believe our current cash runway takes us into 2023.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-11 16:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BioCryst&nbsp;shares&nbsp;jumped&nbsp;10.49%&nbsp;in&nbsp;premarket&nbsp;trading,as&nbsp;withdrawing previous stock offering.</p>\n<p><img src=\"https://static.tigerbbs.com/c15bfde15a241770cbb0410850f6460f\" tg-width=\"900\" tg-height=\"624\" referrerpolicy=\"no-referrer\">BioCryst Pharmaceuticals, Inc. &nbsp;announced today that it has withdrawn its proposed public offering. With our strong balance sheet, and increasing revenues from ORLADEYO<b>®</b> (berotralstat), we believe that current market conditions are not conducive to an offering on terms that would be in the best interests of our current stockholders.&nbsp;&nbsp; We are well capitalized, with cash, cash equivalents, restricted cash and investments of $222.8 million as of June 30, 2021.&nbsp;&nbsp; Based on our expectations for revenue, operating expenses, and our option to access an additional $75 million from our existing credit facility, we believe our current cash runway takes us into 2023.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BCRX":"BioCryst制药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1172810796","content_text":"BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.\nBioCryst Pharmaceuticals, Inc.  announced today that it has withdrawn its proposed public offering. With our strong balance sheet, and increasing revenues from ORLADEYO® (berotralstat), we believe that current market conditions are not conducive to an offering on terms that would be in the best interests of our current stockholders.   We are well capitalized, with cash, cash equivalents, restricted cash and investments of $222.8 million as of June 30, 2021.   Based on our expectations for revenue, operating expenses, and our option to access an additional $75 million from our existing credit facility, we believe our current cash runway takes us into 2023.","news_type":1},"isVote":1,"tweetType":1,"viewCount":567,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":892562154,"gmtCreate":1628673624378,"gmtModify":1676529817158,"author":{"id":"3586309751267683","authorId":"3586309751267683","name":"Kengyong888","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586309751267683","authorIdStr":"3586309751267683"},"themes":[],"htmlText":"Let’s see whether they issue PR today to shedmore light !!","listText":"Let’s see whether they issue PR today to shedmore light !!","text":"Let’s see whether they issue PR today to shedmore light !!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/892562154","repostId":"1172810796","repostType":4,"repost":{"id":"1172810796","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628671712,"share":"https://ttm.financial/m/news/1172810796?lang=&edition=fundamental","pubTime":"2021-08-11 16:48","market":"us","language":"en","title":"BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.","url":"https://stock-news.laohu8.com/highlight/detail?id=1172810796","media":"Tiger Newspress","summary":"BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.\nBioCryst ","content":"<p>BioCryst&nbsp;shares&nbsp;jumped&nbsp;10.49%&nbsp;in&nbsp;premarket&nbsp;trading,as&nbsp;withdrawing previous stock offering.</p>\n<p><img src=\"https://static.tigerbbs.com/c15bfde15a241770cbb0410850f6460f\" tg-width=\"900\" tg-height=\"624\" referrerpolicy=\"no-referrer\">BioCryst Pharmaceuticals, Inc. &nbsp;announced today that it has withdrawn its proposed public offering. With our strong balance sheet, and increasing revenues from ORLADEYO<b>®</b> (berotralstat), we believe that current market conditions are not conducive to an offering on terms that would be in the best interests of our current stockholders.&nbsp;&nbsp; We are well capitalized, with cash, cash equivalents, restricted cash and investments of $222.8 million as of June 30, 2021.&nbsp;&nbsp; Based on our expectations for revenue, operating expenses, and our option to access an additional $75 million from our existing credit facility, we believe our current cash runway takes us into 2023.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-11 16:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BioCryst&nbsp;shares&nbsp;jumped&nbsp;10.49%&nbsp;in&nbsp;premarket&nbsp;trading,as&nbsp;withdrawing previous stock offering.</p>\n<p><img src=\"https://static.tigerbbs.com/c15bfde15a241770cbb0410850f6460f\" tg-width=\"900\" tg-height=\"624\" referrerpolicy=\"no-referrer\">BioCryst Pharmaceuticals, Inc. &nbsp;announced today that it has withdrawn its proposed public offering. With our strong balance sheet, and increasing revenues from ORLADEYO<b>®</b> (berotralstat), we believe that current market conditions are not conducive to an offering on terms that would be in the best interests of our current stockholders.&nbsp;&nbsp; We are well capitalized, with cash, cash equivalents, restricted cash and investments of $222.8 million as of June 30, 2021.&nbsp;&nbsp; Based on our expectations for revenue, operating expenses, and our option to access an additional $75 million from our existing credit facility, we believe our current cash runway takes us into 2023.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BCRX":"BioCryst制药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1172810796","content_text":"BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.\nBioCryst Pharmaceuticals, Inc.  announced today that it has withdrawn its proposed public offering. With our strong balance sheet, and increasing revenues from ORLADEYO® (berotralstat), we believe that current market conditions are not conducive to an offering on terms that would be in the best interests of our current stockholders.   We are well capitalized, with cash, cash equivalents, restricted cash and investments of $222.8 million as of June 30, 2021.   Based on our expectations for revenue, operating expenses, and our option to access an additional $75 million from our existing credit facility, we believe our current cash runway takes us into 2023.","news_type":1},"isVote":1,"tweetType":1,"viewCount":637,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":893352705,"gmtCreate":1628240529507,"gmtModify":1703503784727,"author":{"id":"3586309751267683","authorId":"3586309751267683","name":"Kengyong888","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586309751267683","authorIdStr":"3586309751267683"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/GRTS\">$Gritstone Oncology Inc.(GRTS)$</a>Heavy manipulated from $10+ down to $6.4 !","listText":"<a href=\"https://laohu8.com/S/GRTS\">$Gritstone Oncology Inc.(GRTS)$</a>Heavy manipulated from $10+ down to $6.4 !","text":"$Gritstone Oncology Inc.(GRTS)$Heavy manipulated from $10+ down to $6.4 !","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/893352705","isVote":1,"tweetType":1,"viewCount":543,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":893352358,"gmtCreate":1628240462074,"gmtModify":1703503783558,"author":{"id":"3586309751267683","authorId":"3586309751267683","name":"Kengyong888","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586309751267683","authorIdStr":"3586309751267683"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/GRTS\">$Gritstone Oncology Inc.(GRTS)$</a>BO may be imminent! !","listText":"<a href=\"https://laohu8.com/S/GRTS\">$Gritstone Oncology Inc.(GRTS)$</a>BO may be imminent! !","text":"$Gritstone Oncology Inc.(GRTS)$BO may be imminent! !","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/893352358","isVote":1,"tweetType":1,"viewCount":535,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":802588117,"gmtCreate":1627788379039,"gmtModify":1703495882246,"author":{"id":"3586309751267683","authorId":"3586309751267683","name":"Kengyong888","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586309751267683","authorIdStr":"3586309751267683"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/GRTS\">$Gritstone Oncology Inc.(GRTS)$</a>If the trial of 2nd gen covid vaccine is positive, this will be explosive !","listText":"<a href=\"https://laohu8.com/S/GRTS\">$Gritstone Oncology Inc.(GRTS)$</a>If the trial of 2nd gen covid vaccine is positive, this will be explosive !","text":"$Gritstone Oncology Inc.(GRTS)$If the trial of 2nd gen covid vaccine is positive, this will be explosive !","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/802588117","isVote":1,"tweetType":1,"viewCount":512,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":802581927,"gmtCreate":1627788290769,"gmtModify":1703495880292,"author":{"id":"3586309751267683","authorId":"3586309751267683","name":"Kengyong888","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586309751267683","authorIdStr":"3586309751267683"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/GRTS\">$Gritstone Oncology Inc.(GRTS)$</a>Expect to see few PR on several of their trial results in Aug or Sep. This may push share price to doubledigits !","listText":"<a href=\"https://laohu8.com/S/GRTS\">$Gritstone Oncology Inc.(GRTS)$</a>Expect to see few PR on several of their trial results in Aug or Sep. This may push share price to doubledigits !","text":"$Gritstone Oncology Inc.(GRTS)$Expect to see few PR on several of their trial results in Aug or Sep. This may push share price to doubledigits !","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/802581927","isVote":1,"tweetType":1,"viewCount":374,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":803890106,"gmtCreate":1627430501705,"gmtModify":1703489698023,"author":{"id":"3586309751267683","authorId":"3586309751267683","name":"Kengyong888","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586309751267683","authorIdStr":"3586309751267683"},"themes":[],"htmlText":"Coffee sells","listText":"Coffee sells","text":"Coffee sells","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/803890106","repostId":"1180374779","repostType":4,"isVote":1,"tweetType":1,"viewCount":526,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":172857313,"gmtCreate":1626954476832,"gmtModify":1703481241095,"author":{"id":"3586309751267683","authorId":"3586309751267683","name":"Kengyong888","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586309751267683","authorIdStr":"3586309751267683"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BCRX\">$Biocryst Pharmaceuticals(BCRX)$</a>2Q results to be released on 5th Aug EST morning… today seeking alpha got a positive write up… May dip early morning but close green imo&nbsp;","listText":"<a href=\"https://laohu8.com/S/BCRX\">$Biocryst Pharmaceuticals(BCRX)$</a>2Q results to be released on 5th Aug EST morning… today seeking alpha got a positive write up… May dip early morning but close green imo&nbsp;","text":"$Biocryst Pharmaceuticals(BCRX)$2Q results to be released on 5th Aug EST morning… today seeking alpha got a positive write up… May dip early morning but close green imo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/172857313","isVote":1,"tweetType":1,"viewCount":317,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":148431847,"gmtCreate":1626001751389,"gmtModify":1703751817928,"author":{"id":"3586309751267683","authorId":"3586309751267683","name":"Kengyong888","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586309751267683","authorIdStr":"3586309751267683"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BCTX\">$BriaCell Therapeutics Corp.(BCTX)$</a>One of the largest % gainers last Friday…. Went up high of 6.44 buy closed at 5.63. Next week presentation at virtual conf… will retest above $6 again !","listText":"<a href=\"https://laohu8.com/S/BCTX\">$BriaCell Therapeutics Corp.(BCTX)$</a>One of the largest % gainers last Friday…. Went up high of 6.44 buy closed at 5.63. Next week presentation at virtual conf… will retest above $6 again !","text":"$BriaCell Therapeutics Corp.(BCTX)$One of the largest % gainers last Friday…. Went up high of 6.44 buy closed at 5.63. Next week presentation at virtual conf… will retest above $6 again !","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/148431847","isVote":1,"tweetType":1,"viewCount":598,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":148433476,"gmtCreate":1626001572095,"gmtModify":1703751816949,"author":{"id":"3586309751267683","authorId":"3586309751267683","name":"Kengyong888","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586309751267683","authorIdStr":"3586309751267683"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ONCT\">$Oncternal Therapeutics, Inc.(ONCT)$</a>This probably one of the most undervalued biocancer stocks… &nbsp;waiting for BO and&nbsp;will load more if it dips to 4.3…&nbsp;","listText":"<a href=\"https://laohu8.com/S/ONCT\">$Oncternal Therapeutics, Inc.(ONCT)$</a>This probably one of the most undervalued biocancer stocks… &nbsp;waiting for BO and&nbsp;will load more if it dips to 4.3…&nbsp;","text":"$Oncternal Therapeutics, Inc.(ONCT)$This probably one of the most undervalued biocancer stocks… waiting for BO and will load more if it dips to 4.3…","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/148433476","isVote":1,"tweetType":1,"viewCount":286,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":861037819,"gmtCreate":1632441661431,"gmtModify":1676530782593,"author":{"id":"3586309751267683","authorId":"3586309751267683","name":"Kengyong888","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586309751267683","authorIdStr":"3586309751267683"},"themes":[],"htmlText":"Yup… can travel&nbsp;","listText":"Yup… can travel&nbsp;","text":"Yup… can travel","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":4,"repostSize":0,"link":"https://ttm.financial/post/861037819","repostId":"2169955066","repostType":4,"isVote":1,"tweetType":1,"viewCount":755,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":159049162,"gmtCreate":1624932843356,"gmtModify":1703848254470,"author":{"id":"3586309751267683","authorId":"3586309751267683","name":"Kengyong888","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586309751267683","authorIdStr":"3586309751267683"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BCTX\">$BriaCell Therapeutics Corp.(BCTX)$</a>New SSH (Marc Lustig of&nbsp;L5 capital)&nbsp;announced yesterday after market closed. Plus conference tomorrow AM.&nbsp;Time to go above $6again&nbsp;","listText":"<a href=\"https://laohu8.com/S/BCTX\">$BriaCell Therapeutics Corp.(BCTX)$</a>New SSH (Marc Lustig of&nbsp;L5 capital)&nbsp;announced yesterday after market closed. Plus conference tomorrow AM.&nbsp;Time to go above $6again&nbsp;","text":"$BriaCell Therapeutics Corp.(BCTX)$New SSH (Marc Lustig of L5 capital) announced yesterday after market closed. Plus conference tomorrow AM. Time to go above $6again","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":1,"link":"https://ttm.financial/post/159049162","isVote":1,"tweetType":1,"viewCount":714,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":123078147,"gmtCreate":1624405231789,"gmtModify":1703835509087,"author":{"id":"3586309751267683","authorId":"3586309751267683","name":"Kengyong888","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586309751267683","authorIdStr":"3586309751267683"},"themes":[],"htmlText":"Good to steady the market","listText":"Good to steady the market","text":"Good to steady the market","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":1,"link":"https://ttm.financial/post/123078147","repostId":"1165385736","repostType":4,"isVote":1,"tweetType":1,"viewCount":46,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3567166157226906","authorId":"3567166157226906","name":"imteng87","avatar":"https://static.tigerbbs.com/85b7b030b8b0786177d474964394bab4","crmLevel":6,"crmLevelSwitch":0,"idStr":"3567166157226906","authorIdStr":"3567166157226906"},"content":"Like n comment pls. Thanks!","text":"Like n comment pls. Thanks!","html":"Like n comment pls. Thanks!"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":152878216,"gmtCreate":1625284309935,"gmtModify":1703739969615,"author":{"id":"3586309751267683","authorId":"3586309751267683","name":"Kengyong888","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586309751267683","authorIdStr":"3586309751267683"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$</a>Imo, price will drift sideways until the next travel bubble with another Asia country is announced. USmarket is frothy and May see steep correctionand price will come under pressure too. Will take profit and re-enter at 4.8","listText":"<a href=\"https://laohu8.com/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$</a>Imo, price will drift sideways until the next travel bubble with another Asia country is announced. USmarket is frothy and May see steep correctionand price will come under pressure too. Will take profit and re-enter at 4.8","text":"$SINGAPORE AIRLINES LTD(C6L.SI)$Imo, price will drift sideways until the next travel bubble with another Asia country is announced. USmarket is frothy and May see steep correctionand price will come under pressure too. Will take profit and re-enter at 4.8","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/152878216","isVote":1,"tweetType":1,"viewCount":203,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":892562154,"gmtCreate":1628673624378,"gmtModify":1676529817158,"author":{"id":"3586309751267683","authorId":"3586309751267683","name":"Kengyong888","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586309751267683","authorIdStr":"3586309751267683"},"themes":[],"htmlText":"Let’s see whether they issue PR today to shedmore light !!","listText":"Let’s see whether they issue PR today to shedmore light !!","text":"Let’s see whether they issue PR today to shedmore light !!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/892562154","repostId":"1172810796","repostType":4,"repost":{"id":"1172810796","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628671712,"share":"https://ttm.financial/m/news/1172810796?lang=&edition=fundamental","pubTime":"2021-08-11 16:48","market":"us","language":"en","title":"BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.","url":"https://stock-news.laohu8.com/highlight/detail?id=1172810796","media":"Tiger Newspress","summary":"BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.\nBioCryst ","content":"<p>BioCryst&nbsp;shares&nbsp;jumped&nbsp;10.49%&nbsp;in&nbsp;premarket&nbsp;trading,as&nbsp;withdrawing previous stock offering.</p>\n<p><img src=\"https://static.tigerbbs.com/c15bfde15a241770cbb0410850f6460f\" tg-width=\"900\" tg-height=\"624\" referrerpolicy=\"no-referrer\">BioCryst Pharmaceuticals, Inc. &nbsp;announced today that it has withdrawn its proposed public offering. With our strong balance sheet, and increasing revenues from ORLADEYO<b>®</b> (berotralstat), we believe that current market conditions are not conducive to an offering on terms that would be in the best interests of our current stockholders.&nbsp;&nbsp; We are well capitalized, with cash, cash equivalents, restricted cash and investments of $222.8 million as of June 30, 2021.&nbsp;&nbsp; Based on our expectations for revenue, operating expenses, and our option to access an additional $75 million from our existing credit facility, we believe our current cash runway takes us into 2023.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-11 16:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BioCryst&nbsp;shares&nbsp;jumped&nbsp;10.49%&nbsp;in&nbsp;premarket&nbsp;trading,as&nbsp;withdrawing previous stock offering.</p>\n<p><img src=\"https://static.tigerbbs.com/c15bfde15a241770cbb0410850f6460f\" tg-width=\"900\" tg-height=\"624\" referrerpolicy=\"no-referrer\">BioCryst Pharmaceuticals, Inc. &nbsp;announced today that it has withdrawn its proposed public offering. With our strong balance sheet, and increasing revenues from ORLADEYO<b>®</b> (berotralstat), we believe that current market conditions are not conducive to an offering on terms that would be in the best interests of our current stockholders.&nbsp;&nbsp; We are well capitalized, with cash, cash equivalents, restricted cash and investments of $222.8 million as of June 30, 2021.&nbsp;&nbsp; Based on our expectations for revenue, operating expenses, and our option to access an additional $75 million from our existing credit facility, we believe our current cash runway takes us into 2023.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BCRX":"BioCryst制药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1172810796","content_text":"BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.\nBioCryst Pharmaceuticals, Inc.  announced today that it has withdrawn its proposed public offering. With our strong balance sheet, and increasing revenues from ORLADEYO® (berotralstat), we believe that current market conditions are not conducive to an offering on terms that would be in the best interests of our current stockholders.   We are well capitalized, with cash, cash equivalents, restricted cash and investments of $222.8 million as of June 30, 2021.   Based on our expectations for revenue, operating expenses, and our option to access an additional $75 million from our existing credit facility, we believe our current cash runway takes us into 2023.","news_type":1},"isVote":1,"tweetType":1,"viewCount":637,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":124018444,"gmtCreate":1624706080088,"gmtModify":1703843931905,"author":{"id":"3586309751267683","authorId":"3586309751267683","name":"Kengyong888","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586309751267683","authorIdStr":"3586309751267683"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BCTX\">$BriaCell Therapeutics Corp.(BCTX)$</a>CEO presenting on conference on 29th… price will rise Monday or Tue morning","listText":"<a href=\"https://laohu8.com/S/BCTX\">$BriaCell Therapeutics Corp.(BCTX)$</a>CEO presenting on conference on 29th… price will rise Monday or Tue morning","text":"$BriaCell Therapeutics Corp.(BCTX)$CEO presenting on conference on 29th… price will rise Monday or Tue morning","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/124018444","isVote":1,"tweetType":1,"viewCount":548,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3569750028742479","authorId":"3569750028742479","name":"cheekeong","avatar":"https://static.tigerbbs.com/064e35722748144f5c935ee80c48733c","crmLevel":3,"crmLevelSwitch":0,"idStr":"3569750028742479","authorIdStr":"3569750028742479"},"content":"Drop actually...","text":"Drop actually...","html":"Drop actually..."}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":833202134,"gmtCreate":1629243477028,"gmtModify":1676529974721,"author":{"id":"3586309751267683","authorId":"3586309751267683","name":"Kengyong888","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586309751267683","authorIdStr":"3586309751267683"},"themes":[],"htmlText":"Huat !","listText":"Huat !","text":"Huat !","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/833202134","repostId":"1154954467","repostType":4,"isVote":1,"tweetType":1,"viewCount":738,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":892565988,"gmtCreate":1628673652244,"gmtModify":1676529817166,"author":{"id":"3586309751267683","authorId":"3586309751267683","name":"Kengyong888","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586309751267683","authorIdStr":"3586309751267683"},"themes":[],"htmlText":"Short covering today !!","listText":"Short covering today !!","text":"Short covering today !!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/892565988","repostId":"1172810796","repostType":4,"repost":{"id":"1172810796","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628671712,"share":"https://ttm.financial/m/news/1172810796?lang=&edition=fundamental","pubTime":"2021-08-11 16:48","market":"us","language":"en","title":"BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.","url":"https://stock-news.laohu8.com/highlight/detail?id=1172810796","media":"Tiger Newspress","summary":"BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.\nBioCryst ","content":"<p>BioCryst&nbsp;shares&nbsp;jumped&nbsp;10.49%&nbsp;in&nbsp;premarket&nbsp;trading,as&nbsp;withdrawing previous stock offering.</p>\n<p><img src=\"https://static.tigerbbs.com/c15bfde15a241770cbb0410850f6460f\" tg-width=\"900\" tg-height=\"624\" referrerpolicy=\"no-referrer\">BioCryst Pharmaceuticals, Inc. &nbsp;announced today that it has withdrawn its proposed public offering. With our strong balance sheet, and increasing revenues from ORLADEYO<b>®</b> (berotralstat), we believe that current market conditions are not conducive to an offering on terms that would be in the best interests of our current stockholders.&nbsp;&nbsp; We are well capitalized, with cash, cash equivalents, restricted cash and investments of $222.8 million as of June 30, 2021.&nbsp;&nbsp; Based on our expectations for revenue, operating expenses, and our option to access an additional $75 million from our existing credit facility, we believe our current cash runway takes us into 2023.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-11 16:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BioCryst&nbsp;shares&nbsp;jumped&nbsp;10.49%&nbsp;in&nbsp;premarket&nbsp;trading,as&nbsp;withdrawing previous stock offering.</p>\n<p><img src=\"https://static.tigerbbs.com/c15bfde15a241770cbb0410850f6460f\" tg-width=\"900\" tg-height=\"624\" referrerpolicy=\"no-referrer\">BioCryst Pharmaceuticals, Inc. &nbsp;announced today that it has withdrawn its proposed public offering. With our strong balance sheet, and increasing revenues from ORLADEYO<b>®</b> (berotralstat), we believe that current market conditions are not conducive to an offering on terms that would be in the best interests of our current stockholders.&nbsp;&nbsp; We are well capitalized, with cash, cash equivalents, restricted cash and investments of $222.8 million as of June 30, 2021.&nbsp;&nbsp; Based on our expectations for revenue, operating expenses, and our option to access an additional $75 million from our existing credit facility, we believe our current cash runway takes us into 2023.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BCRX":"BioCryst制药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1172810796","content_text":"BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.\nBioCryst Pharmaceuticals, Inc.  announced today that it has withdrawn its proposed public offering. With our strong balance sheet, and increasing revenues from ORLADEYO® (berotralstat), we believe that current market conditions are not conducive to an offering on terms that would be in the best interests of our current stockholders.   We are well capitalized, with cash, cash equivalents, restricted cash and investments of $222.8 million as of June 30, 2021.   Based on our expectations for revenue, operating expenses, and our option to access an additional $75 million from our existing credit facility, we believe our current cash runway takes us into 2023.","news_type":1},"isVote":1,"tweetType":1,"viewCount":567,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":153539176,"gmtCreate":1625032840495,"gmtModify":1703850579594,"author":{"id":"3586309751267683","authorId":"3586309751267683","name":"Kengyong888","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586309751267683","authorIdStr":"3586309751267683"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$</a>Phuket going to announce sandbox model for vaccinated travellers.. guess scoot and SilkAir tickets to Phuket&nbsp;will rise soon&nbsp;","listText":"<a href=\"https://laohu8.com/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$</a>Phuket going to announce sandbox model for vaccinated travellers.. guess scoot and SilkAir tickets to Phuket&nbsp;will rise soon&nbsp;","text":"$SINGAPORE AIRLINES LTD(C6L.SI)$Phuket going to announce sandbox model for vaccinated travellers.. guess scoot and SilkAir tickets to Phuket will rise soon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/153539176","isVote":1,"tweetType":1,"viewCount":150,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":129177975,"gmtCreate":1624367694397,"gmtModify":1703834525217,"author":{"id":"3586309751267683","authorId":"3586309751267683","name":"Kengyong888","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586309751267683","authorIdStr":"3586309751267683"},"themes":[],"htmlText":"Good&nbsp;","listText":"Good&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/129177975","repostId":"1110726798","repostType":4,"repost":{"id":"1110726798","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1624362092,"share":"https://ttm.financial/m/news/1110726798?lang=&edition=fundamental","pubTime":"2021-06-22 19:41","market":"us","language":"en","title":"Toplines Before US Market Open on Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1110726798","media":"Tiger Newspress","summary":"Stock futures rise to extend earlier gains.\nTorchlight Energy Price Gains Premarket.\nGameStop Jumps ","content":"<ul>\n <li>Stock futures rise to extend earlier gains.</li>\n <li>Torchlight Energy Price Gains Premarket.</li>\n <li>GameStop Jumps After Raising More Than $1 Billion in New Shares.</li>\n <li>GameStop, MicroVision, Sanderson Farms &amp; more made the biggest moves in the premarket.</li>\n</ul>\n<p>(June 22)&nbsp;Stock futures rose Tuesday morning to build on gains from a day earlier, with equities recovering from concerns over the path forward for monetary policy last week.</p>\n<p>At 7:47&nbsp;a.m. ET, Dow e-minis were up 23 points, or 0.07%, S&amp;P 500 e-minis were up 5.75 points, or 0.14%, and Nasdaq 100 e-minis were up 39.25 points, or 0.28%.</p>\n<p><img src=\"https://static.tigerbbs.com/127a76b6bde89676371162b1b268b550\" tg-width=\"1242\" tg-height=\"500\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Stocks making the biggest moves in the premarket: GameStop, MicroVision, Sanderson Farms &amp; more</b></p>\n<p><b>1)&nbsp;GameStop(GME)</b> – The videogame retailer's stock jumped 6.8% in the premarket after it had announced it had completed a previously announced sale of 5 million common shares, raising $1.126 billion.</p>\n<p><b>2)&nbsp;MicroVision(MVIS)</b> – MicroVision shares slid 10.8% in the premarket after the laser technology company said it would sell up to $140 million of stock \"from time to time\" and use the funds for general corporate purposes.</p>\n<p><b>3)&nbsp;Sanderson Farms(SAFM) </b>– Sanderson Farms is exploring a possible sale, according to people familiar with the matter who spoke to The Wall Street Journal. The paper said the poultry producer has already drawn interest from suitors such as agricultural investment firm Continental Grain. The stock surged 10% in premarket action.</p>\n<p><b>4)&nbsp;Torchlight Energy Resources(TRCH)</b> – Torchlight shares gained another 4.9% in premarket trading after a 58% surge in Monday's trading. The oil and gas producer is among the stocks getting increased social media attention on sites like Reddit and Stocktwits.</p>\n<p><b>5)&nbsp;Alphabet(GOOGL) </b>– The European Unionhas opened a formal antitrust probeof Google's digital ad practices. Part of the investigation will cover some of the same areas involved in a case filed by several U.S. states against the Alphabet operation last year.</p>\n<p><b>6)&nbsp;Korn Ferry(KFY)</b> – The consulting firm reported quarterly earnings of $1.21 per share, beating the consensus estimate of 98 cents a share. Revenue topped Wall Street forecasts as well, boosted by its services that help businesses with organizational issues.</p>\n<p><b>7)&nbsp;Plug Power(PLUG)</b> – The alternative energy provider lost 12 cents per share for its latest quarter, wider than the 8 cents a share loss analysts were expecting. Revenue also came in below estimates. The company said it was hurt by short-term issues – such as hydrogen shortages and the Texas freeze – which are abating in the current quarter. Plug Power shares gained 1.4% in premarket trading.</p>\n<p><b>8)&nbsp;Boeing(BA)</b> – Boeing announced the departure of lobbyist and political strategist Tim Keating. No reason was given for Keating’s departure, though the company said a search is underway for a permanent replacement. Keating was a key figure helping Boeing navigate the crisis that followed two fatal crashes of the company’s 737 Max jet.</p>\n<p><b>9)&nbsp;Delta Air Lines(DAL) </b>– Delta plans to hire 1,000 more pilots by next summer, according to an internal company memo. The move comes amid a rebound in travel, with Delta saying the leisure travel is already back to pre-pandemic levels and business travel is picking up as well.</p>\n<p><b>10)&nbsp;Lordstown Motors(RIDE)</b> – Lordstown remains on watch today following a 5.5% Monday drop. The electric vehicle maker’s executive chairman Angela Strand said the company is “evaluating strategic partners” as part of its search for new funding.</p>\n<p><b>11)&nbsp;Exxon Mobil(XOM) </b>– Exxon Mobil is denying a Bloomberg report that it plans to cut 5% to 10% of its office workforce annually over the next three to five years. Exxon told CNBC it is merely going through its annual employee assessments, which are unrelated to workforce reductions.</p>\n<p><b>12)&nbsp;CrowdStrike(CRWD) </b>– CrowdStrike was upgraded to “buy” from “hold” at Stifel Financial, which points to the cybersecurity company’s potential to increase profit margins and its ability to acquire new customers. CrowdStrike gained 2.8% in the premarket.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Tuesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Tuesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-22 19:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>Stock futures rise to extend earlier gains.</li>\n <li>Torchlight Energy Price Gains Premarket.</li>\n <li>GameStop Jumps After Raising More Than $1 Billion in New Shares.</li>\n <li>GameStop, MicroVision, Sanderson Farms &amp; more made the biggest moves in the premarket.</li>\n</ul>\n<p>(June 22)&nbsp;Stock futures rose Tuesday morning to build on gains from a day earlier, with equities recovering from concerns over the path forward for monetary policy last week.</p>\n<p>At 7:47&nbsp;a.m. ET, Dow e-minis were up 23 points, or 0.07%, S&amp;P 500 e-minis were up 5.75 points, or 0.14%, and Nasdaq 100 e-minis were up 39.25 points, or 0.28%.</p>\n<p><img src=\"https://static.tigerbbs.com/127a76b6bde89676371162b1b268b550\" tg-width=\"1242\" tg-height=\"500\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Stocks making the biggest moves in the premarket: GameStop, MicroVision, Sanderson Farms &amp; more</b></p>\n<p><b>1)&nbsp;GameStop(GME)</b> – The videogame retailer's stock jumped 6.8% in the premarket after it had announced it had completed a previously announced sale of 5 million common shares, raising $1.126 billion.</p>\n<p><b>2)&nbsp;MicroVision(MVIS)</b> – MicroVision shares slid 10.8% in the premarket after the laser technology company said it would sell up to $140 million of stock \"from time to time\" and use the funds for general corporate purposes.</p>\n<p><b>3)&nbsp;Sanderson Farms(SAFM) </b>– Sanderson Farms is exploring a possible sale, according to people familiar with the matter who spoke to The Wall Street Journal. The paper said the poultry producer has already drawn interest from suitors such as agricultural investment firm Continental Grain. The stock surged 10% in premarket action.</p>\n<p><b>4)&nbsp;Torchlight Energy Resources(TRCH)</b> – Torchlight shares gained another 4.9% in premarket trading after a 58% surge in Monday's trading. The oil and gas producer is among the stocks getting increased social media attention on sites like Reddit and Stocktwits.</p>\n<p><b>5)&nbsp;Alphabet(GOOGL) </b>– The European Unionhas opened a formal antitrust probeof Google's digital ad practices. Part of the investigation will cover some of the same areas involved in a case filed by several U.S. states against the Alphabet operation last year.</p>\n<p><b>6)&nbsp;Korn Ferry(KFY)</b> – The consulting firm reported quarterly earnings of $1.21 per share, beating the consensus estimate of 98 cents a share. Revenue topped Wall Street forecasts as well, boosted by its services that help businesses with organizational issues.</p>\n<p><b>7)&nbsp;Plug Power(PLUG)</b> – The alternative energy provider lost 12 cents per share for its latest quarter, wider than the 8 cents a share loss analysts were expecting. Revenue also came in below estimates. The company said it was hurt by short-term issues – such as hydrogen shortages and the Texas freeze – which are abating in the current quarter. Plug Power shares gained 1.4% in premarket trading.</p>\n<p><b>8)&nbsp;Boeing(BA)</b> – Boeing announced the departure of lobbyist and political strategist Tim Keating. No reason was given for Keating’s departure, though the company said a search is underway for a permanent replacement. Keating was a key figure helping Boeing navigate the crisis that followed two fatal crashes of the company’s 737 Max jet.</p>\n<p><b>9)&nbsp;Delta Air Lines(DAL) </b>– Delta plans to hire 1,000 more pilots by next summer, according to an internal company memo. The move comes amid a rebound in travel, with Delta saying the leisure travel is already back to pre-pandemic levels and business travel is picking up as well.</p>\n<p><b>10)&nbsp;Lordstown Motors(RIDE)</b> – Lordstown remains on watch today following a 5.5% Monday drop. The electric vehicle maker’s executive chairman Angela Strand said the company is “evaluating strategic partners” as part of its search for new funding.</p>\n<p><b>11)&nbsp;Exxon Mobil(XOM) </b>– Exxon Mobil is denying a Bloomberg report that it plans to cut 5% to 10% of its office workforce annually over the next three to five years. Exxon told CNBC it is merely going through its annual employee assessments, which are unrelated to workforce reductions.</p>\n<p><b>12)&nbsp;CrowdStrike(CRWD) </b>– CrowdStrike was upgraded to “buy” from “hold” at Stifel Financial, which points to the cybersecurity company’s potential to increase profit margins and its ability to acquire new customers. CrowdStrike gained 2.8% in the premarket.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite","SPY":"标普500ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1110726798","content_text":"Stock futures rise to extend earlier gains.\nTorchlight Energy Price Gains Premarket.\nGameStop Jumps After Raising More Than $1 Billion in New Shares.\nGameStop, MicroVision, Sanderson Farms & more made the biggest moves in the premarket.\n\n(June 22) Stock futures rose Tuesday morning to build on gains from a day earlier, with equities recovering from concerns over the path forward for monetary policy last week.\nAt 7:47 a.m. ET, Dow e-minis were up 23 points, or 0.07%, S&P 500 e-minis were up 5.75 points, or 0.14%, and Nasdaq 100 e-minis were up 39.25 points, or 0.28%.\n\nStocks making the biggest moves in the premarket: GameStop, MicroVision, Sanderson Farms & more\n1) GameStop(GME) – The videogame retailer's stock jumped 6.8% in the premarket after it had announced it had completed a previously announced sale of 5 million common shares, raising $1.126 billion.\n2) MicroVision(MVIS) – MicroVision shares slid 10.8% in the premarket after the laser technology company said it would sell up to $140 million of stock \"from time to time\" and use the funds for general corporate purposes.\n3) Sanderson Farms(SAFM) – Sanderson Farms is exploring a possible sale, according to people familiar with the matter who spoke to The Wall Street Journal. The paper said the poultry producer has already drawn interest from suitors such as agricultural investment firm Continental Grain. The stock surged 10% in premarket action.\n4) Torchlight Energy Resources(TRCH) – Torchlight shares gained another 4.9% in premarket trading after a 58% surge in Monday's trading. The oil and gas producer is among the stocks getting increased social media attention on sites like Reddit and Stocktwits.\n5) Alphabet(GOOGL) – The European Unionhas opened a formal antitrust probeof Google's digital ad practices. Part of the investigation will cover some of the same areas involved in a case filed by several U.S. states against the Alphabet operation last year.\n6) Korn Ferry(KFY) – The consulting firm reported quarterly earnings of $1.21 per share, beating the consensus estimate of 98 cents a share. Revenue topped Wall Street forecasts as well, boosted by its services that help businesses with organizational issues.\n7) Plug Power(PLUG) – The alternative energy provider lost 12 cents per share for its latest quarter, wider than the 8 cents a share loss analysts were expecting. Revenue also came in below estimates. The company said it was hurt by short-term issues – such as hydrogen shortages and the Texas freeze – which are abating in the current quarter. Plug Power shares gained 1.4% in premarket trading.\n8) Boeing(BA) – Boeing announced the departure of lobbyist and political strategist Tim Keating. No reason was given for Keating’s departure, though the company said a search is underway for a permanent replacement. Keating was a key figure helping Boeing navigate the crisis that followed two fatal crashes of the company’s 737 Max jet.\n9) Delta Air Lines(DAL) – Delta plans to hire 1,000 more pilots by next summer, according to an internal company memo. The move comes amid a rebound in travel, with Delta saying the leisure travel is already back to pre-pandemic levels and business travel is picking up as well.\n10) Lordstown Motors(RIDE) – Lordstown remains on watch today following a 5.5% Monday drop. The electric vehicle maker’s executive chairman Angela Strand said the company is “evaluating strategic partners” as part of its search for new funding.\n11) Exxon Mobil(XOM) – Exxon Mobil is denying a Bloomberg report that it plans to cut 5% to 10% of its office workforce annually over the next three to five years. Exxon told CNBC it is merely going through its annual employee assessments, which are unrelated to workforce reductions.\n12) CrowdStrike(CRWD) – CrowdStrike was upgraded to “buy” from “hold” at Stifel Financial, which points to the cybersecurity company’s potential to increase profit margins and its ability to acquire new customers. CrowdStrike gained 2.8% in the premarket.","news_type":1},"isVote":1,"tweetType":1,"viewCount":74,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":803890106,"gmtCreate":1627430501705,"gmtModify":1703489698023,"author":{"id":"3586309751267683","authorId":"3586309751267683","name":"Kengyong888","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586309751267683","authorIdStr":"3586309751267683"},"themes":[],"htmlText":"Coffee sells","listText":"Coffee sells","text":"Coffee sells","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/803890106","repostId":"1180374779","repostType":4,"repost":{"id":"1180374779","pubTimestamp":1627429671,"share":"https://ttm.financial/m/news/1180374779?lang=&edition=fundamental","pubTime":"2021-07-28 07:47","market":"us","language":"en","title":"Starbucks forecasts steamy sales despite pressure in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1180374779","media":"Reuters","summary":"Starbucks Corp forecast fourth-quarter sales above Wall Street estimates on Tuesday despite headwind","content":"<p>Starbucks Corp&nbsp;forecast fourth-quarter sales above Wall Street estimates on Tuesday despite headwinds in China as travel restrictions related to COVID-19 loom longer than expected.</p>\n<p>The coffee chain forecast comparable sales for its current quarter to grow 18% to 21%, expecting strength in the Americas. Analysts on average expect growth of 17.5%, according to IBES data from Refinitiv.</p>\n<p>But the Delta variant of the coronavirus has triggered a surge of new COVID-19 cases and the reinstatement of mask rules in some places.</p>\n<p>The United States said on Monday that it will not lift existing travel restrictions.</p>\n<p>In the third quarter ended June 27, sales rose 19% in China - Starbucks' biggest growth market - despite a resurgence of COVID-19 in the south, Belinda Wong, chief executive officer of Starbucks China, said on a call with analysts.</p>\n<p>Starbucks lowered its fiscal 2021 forecast for China sales growth to 18-20% from 27-32%, and it dropped its international sales forecast to 15-17% from 25-30%.</p>\n<p>The company's previous guidance for China had \"assumed a shorter time frame for the lifting of travel restrictions and also less of the uncertainties that we have faced in the market,\" Wong said of the revision.</p>\n<p>The volatility is \"only temporary\" and the company is on track to add more than 600 net new stores in China this fiscal year, she said.</p>\n<p>Shares fell 3.3% in extended trading.</p>\n<p>In the United States, the easing of COVID-19 restrictions on travel and restaurant capacity, as well as reopening of some offices have boosted sales at Starbucks and other big U.S. restaurants, including Chipotle Mexican Grill(CMG.N)and Domino's Pizza(DPZ.N).</p>\n<p>Starbucks' U.S. quarterly sales soared 83% over the previous year - in part as urban areas recovered with people returning to businesses - and 10% above pre-pandemic levels two years ago.</p>\n<p>Those results helped lift global sales 73% compared to estimates of 69.4% growth.</p>\n<p>The company has also been pushing its digital business - its rewards program grew 48% to 24.2 million members - and new beverages, including three flavors of ready-to-drink coffee.</p>\n<p>Its cold drinks also grew to 74% of beverage sales in the quarter.</p>\n<p>Excluding certain items, Starbucks earned $1.01 per share, compared with a loss of 46 cents a year earlier. That exceeded analysts' estimates of 78 cents a share.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Starbucks forecasts steamy sales despite pressure in China</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStarbucks forecasts steamy sales despite pressure in China\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-28 07:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.reuters.com/business/starbucks-delivers-steaming-results-customers-return-stores-2021-07-27/><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Starbucks Corp forecast fourth-quarter sales above Wall Street estimates on Tuesday despite headwinds in China as travel restrictions related to COVID-19 loom longer than expected.\nThe coffee chain ...</p>\n\n<a href=\"https://www.reuters.com/business/starbucks-delivers-steaming-results-customers-return-stores-2021-07-27/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SBUX":"星巴克"},"source_url":"https://www.reuters.com/business/starbucks-delivers-steaming-results-customers-return-stores-2021-07-27/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1180374779","content_text":"Starbucks Corp forecast fourth-quarter sales above Wall Street estimates on Tuesday despite headwinds in China as travel restrictions related to COVID-19 loom longer than expected.\nThe coffee chain forecast comparable sales for its current quarter to grow 18% to 21%, expecting strength in the Americas. Analysts on average expect growth of 17.5%, according to IBES data from Refinitiv.\nBut the Delta variant of the coronavirus has triggered a surge of new COVID-19 cases and the reinstatement of mask rules in some places.\nThe United States said on Monday that it will not lift existing travel restrictions.\nIn the third quarter ended June 27, sales rose 19% in China - Starbucks' biggest growth market - despite a resurgence of COVID-19 in the south, Belinda Wong, chief executive officer of Starbucks China, said on a call with analysts.\nStarbucks lowered its fiscal 2021 forecast for China sales growth to 18-20% from 27-32%, and it dropped its international sales forecast to 15-17% from 25-30%.\nThe company's previous guidance for China had \"assumed a shorter time frame for the lifting of travel restrictions and also less of the uncertainties that we have faced in the market,\" Wong said of the revision.\nThe volatility is \"only temporary\" and the company is on track to add more than 600 net new stores in China this fiscal year, she said.\nShares fell 3.3% in extended trading.\nIn the United States, the easing of COVID-19 restrictions on travel and restaurant capacity, as well as reopening of some offices have boosted sales at Starbucks and other big U.S. restaurants, including Chipotle Mexican Grill(CMG.N)and Domino's Pizza(DPZ.N).\nStarbucks' U.S. quarterly sales soared 83% over the previous year - in part as urban areas recovered with people returning to businesses - and 10% above pre-pandemic levels two years ago.\nThose results helped lift global sales 73% compared to estimates of 69.4% growth.\nThe company has also been pushing its digital business - its rewards program grew 48% to 24.2 million members - and new beverages, including three flavors of ready-to-drink coffee.\nIts cold drinks also grew to 74% of beverage sales in the quarter.\nExcluding certain items, Starbucks earned $1.01 per share, compared with a loss of 46 cents a year earlier. That exceeded analysts' estimates of 78 cents a share.","news_type":1},"isVote":1,"tweetType":1,"viewCount":526,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":163510772,"gmtCreate":1623888564596,"gmtModify":1703822455888,"author":{"id":"3586309751267683","authorId":"3586309751267683","name":"Kengyong888","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586309751267683","authorIdStr":"3586309751267683"},"themes":[],"htmlText":"Bank stocks will rise soon","listText":"Bank stocks will rise soon","text":"Bank stocks will rise soon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/163510772","repostId":"2144270718","repostType":4,"repost":{"id":"2144270718","pubTimestamp":1623879249,"share":"https://ttm.financial/m/news/2144270718?lang=&edition=fundamental","pubTime":"2021-06-17 05:34","market":"us","language":"en","title":"Fed Sees Two Rate Hikes by End of 2023, Inches Towards Taper","url":"https://stock-news.laohu8.com/highlight/detail?id=2144270718","media":"Bloomberg","summary":"Thirteen of 18 officials see at least one rate hike in 2023\nPowell says Fed to begin discussing scal","content":"<ul>\n <li>Thirteen of 18 officials see at least one rate hike in 2023</li>\n <li>Powell says Fed to begin discussing scaling back bond buying</li>\n</ul>\n<p>Federal Reserve officials sped up their expected pace of policy tightening amid optimism about the labor market and heightened concerns for inflation.</p>\n<p>Fed Chair Jerome Powell told a press conference Wednesday that officials would begin a discussion about scaling back bond purchases used to support financial markets and the economy during the pandemic.</p>\n<p>They also released forecasts that show they anticipate two interest-rate increases by the end of 2023 -- sooner than many thought -- and they upgraded estimates for inflation for the next three years.</p>\n<p>“The economy has clearly made progress,” Powell said after a two-day gathering of the Federal Open Market Committee. “You can think of this meeting as the talking-about-talking-about meeting, if you like,” he added, referring to the discussion about tapering purchases.</p>\n<p><img src=\"https://static.tigerbbs.com/b2eca74e7277de2e0f189f2489e9069e\" tg-width=\"1367\" tg-height=\"616\"></p>\n<p>The central bank&nbsp;held the target range&nbsp;for its benchmark policy rate unchanged at zero to 0.25%, where it’s been since March 2020, and maintained the $120 billion pace of its monthly bond purchases. The Federal Open Market Committee vote was unanimous.</p>\n<p>The more aggressive signal from the Fed’s forecasts saw the dollar rise, stocks decline and yields on 10-year Treasuries jump.</p>\n<p>“It’s a hawkish surprise,” said Thomas Costerg, senior U.S. economist at Pictet Wealth Management, referring to the rate projections. “We are looking at a Fed that seems positively surprised by the speed of vaccinations and the ongoing withdrawal of social-distancing measures.”</p>\n<p>The quarterly projections showed 13 of 18 officials favored at least one rate increase by the end of 2023, versus seven in March. Eleven officials saw at least two hikes by the end of that year. In addition, seven of them saw a move as early as 2022, up from four.</p>\n<p>“The dots should be taken with a big grain of salt,” Powell said, referring to the interest-rate forecasts. He cautioned that discussions about raising rates would be “highly premature.”</p>\n<p>The Fed marked up its inflation forecasts through the end of 2023. Officials see their preferred measure of price pressures rising 3.4% in 2021 compared with a March projection of 2.4%. The 2022 forecast rose to 2.1% from 2%, and the 2023 estimate was raised to 2.2% from 2.1%.</p>\n<p>Consumer-price pressures have proven hotter than expected over the last two months. Labor Department figures showed a 0.8% jump in prices in April and a 0.6% rise in May, marking the two biggest monthly increases since 2009.</p>\n<p><img src=\"https://static.tigerbbs.com/b6a86414293205edfd0f505fd64c5ef7\" tg-width=\"1200\" tg-height=\"675\"></p>\n<p>“As the reopening continues, shifts in demand can be large and rapid, and bottlenecks, hiring difficulties and other constraints could continue to limit how quickly supply can adjust -- raising the possibility that inflation could turn out to be higher and more persistent than we expect,” Powell said.</p>\n<p>Labor Department reports on employment published since the last gathering of the FOMC in late April, on the other hand, have disappointed relative to forecasters’ expectations. The U.S. unemployment rate was still elevated at 5.8% in May, with total employment still millions of jobs below pre-pandemic levels.</p>\n<p>Even so, the FOMC median projection for unemployment in the fourth quarter of 2021 was unchanged at 4.5%, and the median estimate for the same quarter a year later was marked down to 3.8% from 3.9%. The 2023 forecast was held at 3.5%.</p>\n<p>“I am confident that we are on a path to a very strong labor market,” Powell told reporters. “We learned during the course of the last very long expansion, the longest in our history, that labor supply during a long expansion can exceed expectations.”</p>\n<p><b>GDP Forecasts</b></p>\n<p>The U.S. economic recovery is gathering strength as business restrictions lift and social activity increases across the country. Robust demand from consumers and businesses alike has outstripped capacity, leading to bottlenecks in the supply chain, longer lead times and higher prices.</p>\n<p>Fed officials have said such “fits and starts” are to be expected given the unprecedented nature of the pandemic and expressed optimism about the outlook for the second half of the year as more Americans get vaccinated.</p>\n<p>The FOMC raised its projections for economic growth. Gross domestic product was seen expanding 7% this year, up from a prior projection of 6.5%. It maintained the 2022 expansion forecast at 3.3% and raised the 2023 estimate to 2.4% from March’s 2.2%.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fed Sees Two Rate Hikes by End of 2023, Inches Towards Taper</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFed Sees Two Rate Hikes by End of 2023, Inches Towards Taper\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-17 05:34 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-16/fed-holds-rates-at-zero-projects-two-hikes-by-the-end-of-2023?srnd=premium-asia><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Thirteen of 18 officials see at least one rate hike in 2023\nPowell says Fed to begin discussing scaling back bond buying\n\nFederal Reserve officials sped up their expected pace of policy tightening ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-16/fed-holds-rates-at-zero-projects-two-hikes-by-the-end-of-2023?srnd=premium-asia\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"source_url":"https://www.bloomberg.com/news/articles/2021-06-16/fed-holds-rates-at-zero-projects-two-hikes-by-the-end-of-2023?srnd=premium-asia","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2144270718","content_text":"Thirteen of 18 officials see at least one rate hike in 2023\nPowell says Fed to begin discussing scaling back bond buying\n\nFederal Reserve officials sped up their expected pace of policy tightening amid optimism about the labor market and heightened concerns for inflation.\nFed Chair Jerome Powell told a press conference Wednesday that officials would begin a discussion about scaling back bond purchases used to support financial markets and the economy during the pandemic.\nThey also released forecasts that show they anticipate two interest-rate increases by the end of 2023 -- sooner than many thought -- and they upgraded estimates for inflation for the next three years.\n“The economy has clearly made progress,” Powell said after a two-day gathering of the Federal Open Market Committee. “You can think of this meeting as the talking-about-talking-about meeting, if you like,” he added, referring to the discussion about tapering purchases.\n\nThe central bank held the target range for its benchmark policy rate unchanged at zero to 0.25%, where it’s been since March 2020, and maintained the $120 billion pace of its monthly bond purchases. The Federal Open Market Committee vote was unanimous.\nThe more aggressive signal from the Fed’s forecasts saw the dollar rise, stocks decline and yields on 10-year Treasuries jump.\n“It’s a hawkish surprise,” said Thomas Costerg, senior U.S. economist at Pictet Wealth Management, referring to the rate projections. “We are looking at a Fed that seems positively surprised by the speed of vaccinations and the ongoing withdrawal of social-distancing measures.”\nThe quarterly projections showed 13 of 18 officials favored at least one rate increase by the end of 2023, versus seven in March. Eleven officials saw at least two hikes by the end of that year. In addition, seven of them saw a move as early as 2022, up from four.\n“The dots should be taken with a big grain of salt,” Powell said, referring to the interest-rate forecasts. He cautioned that discussions about raising rates would be “highly premature.”\nThe Fed marked up its inflation forecasts through the end of 2023. Officials see their preferred measure of price pressures rising 3.4% in 2021 compared with a March projection of 2.4%. The 2022 forecast rose to 2.1% from 2%, and the 2023 estimate was raised to 2.2% from 2.1%.\nConsumer-price pressures have proven hotter than expected over the last two months. Labor Department figures showed a 0.8% jump in prices in April and a 0.6% rise in May, marking the two biggest monthly increases since 2009.\n\n“As the reopening continues, shifts in demand can be large and rapid, and bottlenecks, hiring difficulties and other constraints could continue to limit how quickly supply can adjust -- raising the possibility that inflation could turn out to be higher and more persistent than we expect,” Powell said.\nLabor Department reports on employment published since the last gathering of the FOMC in late April, on the other hand, have disappointed relative to forecasters’ expectations. The U.S. unemployment rate was still elevated at 5.8% in May, with total employment still millions of jobs below pre-pandemic levels.\nEven so, the FOMC median projection for unemployment in the fourth quarter of 2021 was unchanged at 4.5%, and the median estimate for the same quarter a year later was marked down to 3.8% from 3.9%. The 2023 forecast was held at 3.5%.\n“I am confident that we are on a path to a very strong labor market,” Powell told reporters. “We learned during the course of the last very long expansion, the longest in our history, that labor supply during a long expansion can exceed expectations.”\nGDP Forecasts\nThe U.S. economic recovery is gathering strength as business restrictions lift and social activity increases across the country. Robust demand from consumers and businesses alike has outstripped capacity, leading to bottlenecks in the supply chain, longer lead times and higher prices.\nFed officials have said such “fits and starts” are to be expected given the unprecedented nature of the pandemic and expressed optimism about the outlook for the second half of the year as more Americans get vaccinated.\nThe FOMC raised its projections for economic growth. Gross domestic product was seen expanding 7% this year, up from a prior projection of 6.5%. It maintained the 2022 expansion forecast at 3.3% and raised the 2023 estimate to 2.4% from March’s 2.2%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":90,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":187122982,"gmtCreate":1623747392646,"gmtModify":1704210260153,"author":{"id":"3586309751267683","authorId":"3586309751267683","name":"Kengyong888","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586309751267683","authorIdStr":"3586309751267683"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BCTX\">$BriaCell Therapeutics Corp.(BCTX)$</a>Patience&nbsp;","listText":"<a href=\"https://laohu8.com/S/BCTX\">$BriaCell Therapeutics Corp.(BCTX)$</a>Patience&nbsp;","text":"$BriaCell Therapeutics Corp.(BCTX)$Patience","images":[{"img":"https://static.tigerbbs.com/0bf75b4ad9ad583f33ff8905dec44490","width":"1170","height":"2026"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/187122982","isVote":1,"tweetType":1,"viewCount":42,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9003638760,"gmtCreate":1640956669071,"gmtModify":1676533558409,"author":{"id":"3586309751267683","authorId":"3586309751267683","name":"Kengyong888","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586309751267683","authorIdStr":"3586309751267683"},"themes":[],"htmlText":"Visa !","listText":"Visa !","text":"Visa !","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9003638760","repostId":"2195641730","repostType":4,"isVote":1,"tweetType":1,"viewCount":471,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":187114448,"gmtCreate":1623746472184,"gmtModify":1704210222295,"author":{"id":"3586309751267683","authorId":"3586309751267683","name":"Kengyong888","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586309751267683","authorIdStr":"3586309751267683"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BCTX\">$BriaCell Therapeutics Corp.(BCTX)$</a>Diamonds…","listText":"<a href=\"https://laohu8.com/S/BCTX\">$BriaCell Therapeutics Corp.(BCTX)$</a>Diamonds…","text":"$BriaCell Therapeutics Corp.(BCTX)$Diamonds…","images":[{"img":"https://static.tigerbbs.com/04cee12bf02bf5534dde983696b394df","width":"480","height":"480"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/187114448","isVote":1,"tweetType":1,"viewCount":182,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":892526680,"gmtCreate":1628674576240,"gmtModify":1676529817380,"author":{"id":"3586309751267683","authorId":"3586309751267683","name":"Kengyong888","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586309751267683","authorIdStr":"3586309751267683"},"themes":[],"htmlText":"Someone postulated&nbsp;Poison pill theory in another forum !","listText":"Someone postulated&nbsp;Poison pill theory in another forum !","text":"Someone postulated Poison pill theory in another forum !","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/892526680","repostId":"1172810796","repostType":4,"repost":{"id":"1172810796","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628671712,"share":"https://ttm.financial/m/news/1172810796?lang=&edition=fundamental","pubTime":"2021-08-11 16:48","market":"us","language":"en","title":"BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.","url":"https://stock-news.laohu8.com/highlight/detail?id=1172810796","media":"Tiger Newspress","summary":"BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.\nBioCryst ","content":"<p>BioCryst&nbsp;shares&nbsp;jumped&nbsp;10.49%&nbsp;in&nbsp;premarket&nbsp;trading,as&nbsp;withdrawing previous stock offering.</p>\n<p><img src=\"https://static.tigerbbs.com/c15bfde15a241770cbb0410850f6460f\" tg-width=\"900\" tg-height=\"624\" referrerpolicy=\"no-referrer\">BioCryst Pharmaceuticals, Inc. &nbsp;announced today that it has withdrawn its proposed public offering. With our strong balance sheet, and increasing revenues from ORLADEYO<b>®</b> (berotralstat), we believe that current market conditions are not conducive to an offering on terms that would be in the best interests of our current stockholders.&nbsp;&nbsp; We are well capitalized, with cash, cash equivalents, restricted cash and investments of $222.8 million as of June 30, 2021.&nbsp;&nbsp; Based on our expectations for revenue, operating expenses, and our option to access an additional $75 million from our existing credit facility, we believe our current cash runway takes us into 2023.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-11 16:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BioCryst&nbsp;shares&nbsp;jumped&nbsp;10.49%&nbsp;in&nbsp;premarket&nbsp;trading,as&nbsp;withdrawing previous stock offering.</p>\n<p><img src=\"https://static.tigerbbs.com/c15bfde15a241770cbb0410850f6460f\" tg-width=\"900\" tg-height=\"624\" referrerpolicy=\"no-referrer\">BioCryst Pharmaceuticals, Inc. &nbsp;announced today that it has withdrawn its proposed public offering. With our strong balance sheet, and increasing revenues from ORLADEYO<b>®</b> (berotralstat), we believe that current market conditions are not conducive to an offering on terms that would be in the best interests of our current stockholders.&nbsp;&nbsp; We are well capitalized, with cash, cash equivalents, restricted cash and investments of $222.8 million as of June 30, 2021.&nbsp;&nbsp; Based on our expectations for revenue, operating expenses, and our option to access an additional $75 million from our existing credit facility, we believe our current cash runway takes us into 2023.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BCRX":"BioCryst制药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1172810796","content_text":"BioCryst shares jumped 10.49% in premarket trading,as withdrawing previous stock offering.\nBioCryst Pharmaceuticals, Inc.  announced today that it has withdrawn its proposed public offering. With our strong balance sheet, and increasing revenues from ORLADEYO® (berotralstat), we believe that current market conditions are not conducive to an offering on terms that would be in the best interests of our current stockholders.   We are well capitalized, with cash, cash equivalents, restricted cash and investments of $222.8 million as of June 30, 2021.   Based on our expectations for revenue, operating expenses, and our option to access an additional $75 million from our existing credit facility, we believe our current cash runway takes us into 2023.","news_type":1},"isVote":1,"tweetType":1,"viewCount":569,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":148439528,"gmtCreate":1626001399264,"gmtModify":1703751815153,"author":{"id":"3586309751267683","authorId":"3586309751267683","name":"Kengyong888","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586309751267683","authorIdStr":"3586309751267683"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/INFI\">$Infinity Pharmaceuticals(INFI)$</a>Clinical update&nbsp;data on phase 2 trial&nbsp;will be released on 27th July&nbsp;and webcast is scheduled. Seeking Alpha has a positive article on this. Used fo trade at $3+ and likely&nbsp;to inch up towards 27th !","listText":"<a href=\"https://laohu8.com/S/INFI\">$Infinity Pharmaceuticals(INFI)$</a>Clinical update&nbsp;data on phase 2 trial&nbsp;will be released on 27th July&nbsp;and webcast is scheduled. Seeking Alpha has a positive article on this. Used fo trade at $3+ and likely&nbsp;to inch up towards 27th !","text":"$Infinity Pharmaceuticals(INFI)$Clinical update data on phase 2 trial will be released on 27th July and webcast is scheduled. Seeking Alpha has a positive article on this. Used fo trade at $3+ and likely to inch up towards 27th !","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/148439528","isVote":1,"tweetType":1,"viewCount":366,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":140224519,"gmtCreate":1625663218931,"gmtModify":1703745874121,"author":{"id":"3586309751267683","authorId":"3586309751267683","name":"Kengyong888","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586309751267683","authorIdStr":"3586309751267683"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$</a>Wait fortravel bubbles announcement or work travel schemes.. now delta variant spreading in other Asia countries so it’s also dependent on how ready are&nbsp;other countries&nbsp;","listText":"<a href=\"https://laohu8.com/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$</a>Wait fortravel bubbles announcement or work travel schemes.. now delta variant spreading in other Asia countries so it’s also dependent on how ready are&nbsp;other countries&nbsp;","text":"$SINGAPORE AIRLINES LTD(C6L.SI)$Wait fortravel bubbles announcement or work travel schemes.. now delta variant spreading in other Asia countries so it’s also dependent on how ready are other countries","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/140224519","isVote":1,"tweetType":1,"viewCount":384,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":153664016,"gmtCreate":1625022338135,"gmtModify":1703850343779,"author":{"id":"3586309751267683","authorId":"3586309751267683","name":"Kengyong888","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586309751267683","authorIdStr":"3586309751267683"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ONCT\">$Oncternal Therapeutics, Inc.(ONCT)$</a>BB pushing out retail players.. matter of time IMO&nbsp;","listText":"<a href=\"https://laohu8.com/S/ONCT\">$Oncternal Therapeutics, Inc.(ONCT)$</a>BB pushing out retail players.. matter of time IMO&nbsp;","text":"$Oncternal Therapeutics, Inc.(ONCT)$BB pushing out retail players.. matter of time IMO","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/153664016","isVote":1,"tweetType":1,"viewCount":409,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":124037183,"gmtCreate":1624705472442,"gmtModify":1703843923883,"author":{"id":"3586309751267683","authorId":"3586309751267683","name":"Kengyong888","avatar":"https://static.tigerbbs.com/5bd9f716740b8af854a88febac4f4870","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586309751267683","authorIdStr":"3586309751267683"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ONCT\">$Oncternal Therapeutics, Inc.(ONCT)$</a>Next Monday officially included in Russell 3000 index..From other forum, they withdrew the ATM offering w/o any official PR released yet. Seems like BO coming&nbsp;","listText":"<a href=\"https://laohu8.com/S/ONCT\">$Oncternal Therapeutics, Inc.(ONCT)$</a>Next Monday officially included in Russell 3000 index..From other forum, they withdrew the ATM offering w/o any official PR released yet. Seems like BO coming&nbsp;","text":"$Oncternal Therapeutics, Inc.(ONCT)$Next Monday officially included in Russell 3000 index..From other forum, they withdrew the ATM offering w/o any official PR released yet. Seems like BO coming","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/124037183","isVote":1,"tweetType":1,"viewCount":137,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}